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ABSTRACT 
 
 Eukaryotic linear chromosomes culminate in nucleoprotein structures designated 
telomeres. The terminal telomeric DNA consists of tandem repeats of a G-rich motif that 
is established and maintained by the action of the specialized reverse transcriptase called 
telomerase. In addition to the function of telomerase, the telomere environment requires 
an efficient means to assemble and disassemble a multitude of structures to operate 
correctly and to help achieve cellular homeostasis. Distinct protein assemblies are 
nucleated at telomeric DNA to both guard the ends from damage and lengthen the DNA 
after replication. In yeast, Cdc13 recruits either Stn1-Ten1 to form a protective cap or the 
telomerase holoenzyme to extend the DNA. I have established an in vitro yeast telomere 
system in which Stn1-Ten1-unextendable or telomerase-extendable states can be 
observed. Notably, the yeast Hsp90 chaperone Hsp82 mediates the switch between the 
telomere capping and extending structures by modulating the DNA binding activity of 
Cdc13.  The telomere length and telomerase telomere occupancy also appear to be yeast 
Hsp90 dependent.  Taken together, my data show that the Hsp82 chaperone facilitates 
telomere DNA maintenance by promoting transitions between two operative complexes 
and by reducing the potential for binding events that would otherwise block the assembly 
of downstream structures. 
 The first telomerase cofactor identified was the budding yeast protein Est1, which 
is conserved through humans. While it is evident that Est1 is required for telomere DNA 
maintenance, understanding its mechanistic contributions to telomerase regulation has 
been limited. In vitro, the primary effect of Est1 is to activate telomerase-mediated DNA 
extension. Although Est1 displayed specific DNA and RNA binding, neither activity 
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contributed significantly to telomerase stimulation. Rather Est1 mediated telomerase 
upregulation through direct contacts with the reverse transcriptase subunit.  My studies 
provide insights into the molecular events used to control the enzymatic activity of the 
telomerase holoenzyme.  
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CHAPTER 1
*
 
INTRODUCTION 
 
 The cell interior is a highly dynamic system. In live cells most proteins move with 
apparent diffusion coefficients (0.2–20 μm2s-1) yet within this ostensible chaos the 
separate parts routinely and efficiently organize into multi-step pathways to transduce 
signals or accomplish requisite work (Mitchison, 1992; Misteli, 2001; Bubulya and 
Spector, 2004; Trinkle and Lamond, 2007). The rapid kinetics displayed by individual 
proteins in vivo was not expected since isolated biological complexes are often inherently 
stable in vitro and it had been predicted that the crowded cell interior would impede 
movement (Ellis, 2001; Kushner, 1969; Perham, 1975). However, using advanced 
imaging techniques it is becoming apparent that most cellular components move rapidly 
(Bubulya and Spector, 2004; Lippincott-Schwartz et al., 2000). Despite the visual 
evidence for such fast movements, it is often unclear which factors and events convert 
seemingly stoic in vitro structures into dynamic and efficient systems in vivo.  
 The physiological need for pathways to work both rapidly and selectively within 
the crowded milieu of the cell interior presents great challenges for achieving 
homeostasis in the midst of fluctuating internal and external stimuli. Early biochemical 
work with isolated proteins demonstrated that the specificity of biological complex 
formation can be attributable to cooperative interactions between the individual subunits 
                                                
*
 Figures in this chapter were modified from the following publications 1.) DeZwaan DC 
and Freeman BC. (2010) HSP90 manages the ends. Trends Biochem. Sci., 35: 384-91.    
2.) DeZwaan DC and Freeman BC. (2010) Is there a telomere-bound ‘EST’ telomerase 
holoenzyme? Cell Cycle, 9:1913-17. 
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(Garel et al., 1984). While cooperative associations provide a mechanism for rapid 
assembly, the inherent stability of such organized structures would likely interfere with 
the timing necessary for biological systems. Further complicating proper function is the 
nature of the cell interior: it is densely packed (e.g., the intracellular macromolecular 
concentration is ~350–400 mg ml-1) and often contains multiple binding partners for 
each protein—both features increase the probability for non-productive or off-pathway 
interactions (Minton, 2006). Though it would be possible to avoid these problems if 
proteins assembled into “holo” structures that contain all the components necessary to 
achieve function, this solution is not practical given the crosstalk between and variety of 
cellular paths. 
  Recent proteomic studies underscore the limited use of stable protein structures 
in vivo, as there appear to be only ~500–800 “core” protein complexes that average 3–5 
subunits (Gavin et al., 2002; Krogan et al., 2006). To achieve the diversity necessary for 
life, either individual proteins or the core structures form metastable interactions with a 
variety of accessory factors. The fully assembled complexes would define discrete steps 
along a given pathway and would be dependent upon a dynamic organization in order to 
insure an effective progression. To build each structure with the correct subunits (i.e., 
avoid inappropriate partners) and to foster efficient transitions between the functional 
complexes, cellular factors likely have evolved to destabilize each protein assembly, 
which would be imperative for multi-step pathways. While it is possible that the steady-
state stabilities of individual structures are mediated by unique coevolved factors, the 
probability of this scheme is low, as it would require thousands of additional proteins.  
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Instead, I suggest that molecular chaperones serve to promote a general and continuous 
dynamic protein environment within the cell. 
 To illustrate the potential complexities and obstacles faced by most, if not all, 
biological pathways, I focused on the impact of one molecular chaperone network on a 
single cellular pathway. Specifically, I investigated the potential points of influence that 
the heat shock protein 90 (HSP90) chaperone machinery has on telomere protein biology. 
By coordinating the assembly and disassembly of numerous telomere complexes, I 
speculate that HSP90 and its associated co-chaperones facilitate a precise and efficient 
working environment that is highly beneficial for telomere function.  Once a better 
understanding of Hsp90’s role at the telomere had been established, I further investigate  
components directly involved in the dynamic nature of the telomere maintenance 
pathway.  Thus, I focus on the characterization of an integral telomerase protein 
component called Est1, whose dynamics appear to play a central role in perpetuating a 
functional telomere extension cycle. 
 
The Telomere Protein System 
 Telomeres consist of a tract of G-rich DNA motifs culminating in a 3’ single-
stranded overhang (telomeric DNA) that is recognized by a collection of associated 
factors (telomere-binding proteins) that maintain the terminal DNA at an appropriate 
length to preserve genome stability and cell viability (Gilson and Geli, 2007). A 
multitude of events must occur at telomeres to achieve function and all of the activities 
are challenged by a need to work precisely and efficiently within a limited time-frame. 
Notably, a single shortened telomeric end is sufficient to induce cellular senescence, 
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whereas an unregulated telomere system can lead to malignant growth (Shay and Wright, 
1996; Hemann et al., 2001). Hence, telomere biology presents an ideal molecular model 
to further our understanding of the cellular mechanisms that are required to proficiently 
direct and drive a pathway, which affects homeostasis. 
 Multiple protein complexes assemble at telomeres to execute specific functions 
that are required for protection and extension of the terminal DNA (Gilson and Geli, 
2007; Shore and Bianchi, 2009). In general, the complexity of the telomere varies in 
different stages of the cell cycle; however, specific cellular needs can also direct 
molecular decisions. For instance, telomeric DNA is extended only in S-phase, but not all 
telomeres are extended in every cell cycle (Marcand et al., 2000). In a short temporal 
window (<15 min) during late S-phase, a decision is made on the basis of the length of 
the double-stranded telomeric tract (i.e. the number of telomeric repeats are essentially 
counted) to either generate a telomerase-extendable state or form an unextendable 
structure (Teixeira et al., 2004). 
 If a telomeric end is approaching a critically shortened state, which would trigger 
cellular senescence if reduced further, then the 3’ overhang will be extended (Hemann et 
al., 2001).  Extension of the DNA requires several different aspects of S-phase-specific 
activity, including DNA resectioning, extending and fill-in replicating, which are all 
mediated by distinct protein complexes (Figure 1). Interestingly, components of each 
assemblage are capable of binding to the single-stranded, G-rich overhang, which 
presents the opportunity for inhibitory competitive DNA interactions. Yet, all three 
events operate efficiently within the allotted narrow time window following DNA 
replication in S phase.  If, however, the telomeric DNA tract is sufficiently long, the 
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structure will remain in an unextendable or capped state, although the composition of the 
cap will vary as the cell cycle progresses (Figure 1) (Gilson and Geli, 2007; Shore and 
Bianchi, 2009). Hence, the telomere environment must be maintained in a dynamic state 
in order to respond to the signals that dictate function and to perform the work that is 
required to maintain the chromosomal termini. But what mechanism(s) are used to 
properly assemble (i.e. avoid competitive binding) and disassemble (i.e. transition 
between structures) the various telomere complexes? 
 
Eukaryotic Molecular Chaperone Network 
 Molecular chaperones comprise a diverse protein family that is defined primarily 
by an in vitro activity (i.e. ability to suppress non-native protein aggregation) rather than 
by a conserved amino acid sequence or domain (Ellis and van der Vies, 1991). Chaperone 
family members generally display a promiscuous protein-binding capacity with an 
affinity for short hydrophobic amino acid motifs that likely accounts for the shared ability 
to suppress non-native protein aggregation in vitro (Hendrick and Hartl, 1993). 
Chaperones typically have short-lived, low affinity interactions with a client, which 
offsets the broad binding capacities and avoids interfering with the activity of a target 
protein. These two evolved characteristics make molecular chaperones ideal candidates to 
facilitate a functional dynamic environment comprised of a wide array of proteins. 
 The eukaryotic molecular chaperone system is coordinated primarily around the 
two highly abundant chaperones HSP90 and HSP70 along with their cognate 
cochaperones (Wegele et al., 2004; Mayer and Bukau, 2005). Although many types of 
cellular activity have been identified for the HSP70 network, the general roles of HSP90 
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and its many co-chaperones in vivo (e.g. p23, CDC37, AHA1, and SGT1) remain elusive, 
despite their conservation within eukaryotes. The HSP90 chaperone complex was 
identified originally in stable association with signaling proteins (i.e. kinases and steroid 
receptors) and it has been argued that this chaperone network serves to maintain 
metastable factors in forms that can be readily activated (Pratt and Toft, 2003). However, 
recent proteomic and genetic interaction studies suggest that signaling protein 
maintenance might be the tip of the iceberg for the duties of the eukaryotic HSP90 
chaperone machinery (Millson et al., 2005; Zhao et al., 2005; McClellan et al., 2007). 
 Based on evolutionary considerations, cellular reliance on the HSP90 chaperone 
system has increased significantly. Prokaryotes typically contain a single non-essential 
HSP90 gene (e.g. HtpG in Escherichia coli), yet eukaryotes often have multiple HSP90 
genes that are essential and have acquired a collection of co-chaperone partner proteins 
that do not appear in prokaryotes (Johnson and Brown, 2009). By contrast, HSP70 
proteins are widely regarded as one of the best conserved proteins across the three 
domains of life (Mayer and Bukau, 2005). Yet the functional activities of HSP70 have 
apparently changed as involvement with DNA-associated events has lessened 
(Ziemieowicz et al., 2001). Although the workload shift in the chaperone system likely 
has numerous important physiological consequences, I suspect one key change has been 
employment of the HSP90 machine to foster homeostasis by modulating protein–DNA 
dynamics. 
 Historically, molecular chaperones have been recognized as factors that mediate 
the association and disassociation of protein complexes (Ellis, 2007). Recent studies 
indicate that certain chaperones serve comparable roles with protein–DNA structures 
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(Shaknovich et al., 1992; Freeman and Yamamoto, 2002; Muller et al., 2004; Stavreva et 
al., 2004; Walerych et al., 2004; Toogun et al., 2007; Toogun et al., 2008; DeZwaan et 
al., 2009). For instance, several molecular chaperones, including HSP90, HSP70 and p23, 
can promote protein–DNA dynamics of diverse targets, including components involved 
in RNA transcription, telomere maintenance, DNA repair and DNA replication 
(DeZwaan and Freeman, 2008; Konieczny and Zylicz, 1999; Richter et al., 2007; Hager 
et al., 2009). One aim of my thesis was to focus on the role of the HSP90 chaperone 
system in modulating the assembly and disassembly of telomere structures. 
 
The Hsp90 Machine Associates with the Telomerase Enzyme 
 The initial connection between HSP90 and telomere components was made while 
attempting to identify cellular factors required for telomerase holoenzyme function (Holt 
et al., 1999).  The authors discovered that HSP90 and the p23 co-chaperone interact with 
the protein subunit of human telomerase (hTERT) through a yeast two-hybrid screen. 
Telomerase is a specialized reverse transcriptase (RT) in which the core enzyme 
comprises a protein module (TERT in humans and Est2 in yeast) and an RNA subunit 
(human TR and yeast TLC1) (Gilson and Geli, 2007; Shore and Bianchi, 2009). 
Telomerase utilizes the RNA as a template to extend the 3’ chromosomal ends by 100 
nucleotides or more per cell cycle by reiteratively appending a short (6–8 bases) 
telomeric DNA repeat during each binding event (Teixeira et al., 2004; Britt-Compton et 
al., 2009). Core human telomerase is sufficient for robust DNA extension activity in vitro 
but core yeast telomerase is not (Cohn and Blackburn, 1995; Morin, 1989). Nonetheless, 
both homologs rely on a multitude of additional proteins for proper control; HSP90 and 
 8 
p23 represent the first two proteins shown to interact directly with telomerase and 
contribute to its enzymatic activity (Holt et al., 1999). 
 The link between telomerase and molecular chaperones was extended by the 
finding that additional chaperones, including HSP70, HSP40 and HOP (HSP90/HSP70 
organizing protein), associate with the core human enzyme, presumably to assemble the 
RT and RNA template in vitro (Forsythe et al., 2001). This observation fits with the 
classic steroid receptor–chaperone model in which chaperones are required to generate 
and maintain the hormone-binding state of receptors through a stable interaction that 
persists until the receptor is hormone-activated (Pratt and Toft, 2003). Surprisingly, 
HSP90 and p23 remain associated with telomerase even after extending a telomeric DNA 
substrate, suggesting that these chaperones have a role beyond telomerase protein folding 
(Forsythe et al., 2001). Notably, both HSP90 and p23 also function with DNA-associated 
steroid receptors to promote a dynamic DNA-binding cycle that is required for proper 
gene regulation (Freeman and Yamamoto, 2002; Stavreva et al., 2004). If HSP90 and p23 
regulate both telomerase and receptors at or near DNA, then perhaps these chaperones 
have a general cellular function with diverse DNA-binding proteins. 
 Unpredictably, an early yeast genetic study showed that over-expression of either 
Hsp82 or Hsc82 (the two yeast HSP90 isoforms) led to telomeric DNA shortening, thus 
suggesting a negative effect of Hsp82/Hsc82 in telomere DNA maintenance in vivo 
(Grandin and Charbonneau, 2001). The cause of the decreased telomere DNA length was 
not apparent; however, the potential for Hsp82 to affect telomere-binding proteins 
besides telomerase was revealed when HSP82 was identified as a high-copy suppressor 
of two mutations (cdc13-1 and stn1-157) known to alter telomere DNA length (Grandin  
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and Charbonneau, 2001). Hence, HSP90 proteins might affect multiple telomere 
associated proteins. 
 The observation that telomeric DNA length was essentially normal in a strain 
expressing limited Hsp82 levels ( 10% of normal) further supported the contention that 
Hsp82 does not have a positive effect on telomerase (Grandin and Charbonneau, 2001). 
An Hsp82 protein reduction tactic was used because the eukaryotic HSP90 genes are 
essential and therefore it is not possible to test for in vivo effects in the absence of an 
HSP90 protein. It should be noted, however, that normal yeast has 500,000 Hsp82 
molecules per cell (Ghaemmaghami et al., 2003). Thus, if telomerase is a high-affinity 
substrate for Hsp82, a change in telomeric DNA length might not be expected in yeast 
expressing  50,000 Hsp82 molecules. 
 At the very least, the two initial reports investigating the connection between 
HSP90 and telomere proteins suggested that the relationship is complicated. Although the 
discord between the in vitro and in vivo data might be unsatisfying, it is not entirely 
surprising given the nature of the cellular chaperone network (i.e. abundant and 
promiscuous proteins). For example, HSP70 is the fundamental nascent chain-binding 
protein in vivo (Beckmann et al., 1990). Yet, loss of the E. coli HSP70 gene DnaK results 
in only mild phenotypes (Bukau and Walker, 1989). However, in the absence of both 
DnaK and the trigger factor (TF) molecular chaperone, cells die owing to massive protein 
aggregation (Deuerling et al., 1999). Nonetheless, based on in vitro assays, a role for 
DnaK in protein folding had been long accepted before the discovery of the synthetic 
lethal phenotype between DnaK and TF. Therefore, in vitro studies can identify important 
chaperone functions that are not readily apparent by typical in vivo work given the 
 10
redundant and/or compensatory nature of the cellular molecular chaperone system. To  
dissect the functional role of HSP90 with telomerase, suitable genetic conditions, in 
conjunction with a more detailed biochemical analysis, were necessary. 
 
Combating the End Replication Problem 
 A lack of functional knowledge also surrounded many of the key telomerase co-
factors, whose dynamics had been speculated to assist in avoidance of the “end 
replication problem” associated with telomeric ends.  The “end replication problem” is a 
dilemma that challenges all linear chromosomes (Watson, 1972; Olovnikov, 1973).  The 
DNA replication machinery relies on an RNA primer to initiate synthesis and removal of 
the extreme 5’ RNA oligonucleotide leaves a gap that cannot be filled in by the 
conventional cellular DNA polymerases (Blackburn, 1991).  Thus, the lagging strand 
would shorten with each cell division in the absence of a compensatory mechanism.  In 
addition, the leading strand can be trimmed by 5'-exonuclease activities that are coupled 
to passage of the replication fork (Gilson and Geli, 2007).  Several plausible routes were 
proposed to correct these limitations including the involvement of a nucleotide terminal 
transferase, recombinase or a novel enzyme that might elongate the 3’ ends (Watson, 
1972; Olovnikov, 1973; Shampay et al., 1984).  Ultimately, it was found that a 
specialized reverse transcriptase termed telomerase, which is comprised of protein 
enzyme and RNA template, is required to maintain linear chromosomes by elongating the 
3’ terminus (Greider and Blackburn, 1987; Blackburn et al., 1989). 
 To investigate how chromosomal termini are maintained a genetic screen in 
budding yeast was employed that exploited a cellular senescence phenotype that occurs 
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upon telomere dysfunction (Lundblad and Szostak, 1989).  Telomeric DNA length was 
measured in the genetic isolates, as a secondary screen.  This approach revealed the first 
telomere-associated factor EST1 (Ever Shorter Telomere 1) since the chromosomal 
terminal DNA in est1 yeast is progressively lost and the cells coordinately reach 
replicative senescence.  In a follow-up screen three additional components (EST2, EST3 
and EST4) were uncovered (Lendvay et al., 1996).  Further analysis identified the EST4 
gene to be synonymous with CDC13, which was previously found in a temperature 
sensitive screen used to isolate Cell Division Cycle (CDC) mutants (Hartwell et al., 
1973).  Eventually, it would be realized that these seminal studies discovered the gene 
encoding the telomerase reverse transcriptase Est2, two telomerase regulatory proteins 
(Est1 and 3) and a vital telomeric DNA-binding protein (Cdc13) required for both 
extending and protecting telomeres (Taggart and Zakian, 2003).  Importantly, the four 
EST proteins appear to have structure/function homologs in humans (Linger and Price, 
2009).  A separate study described an RNA component Tlc1 that forms the core 
telomerase enzyme in conjunction with Est2 (Singer and Gottschling, 1994).  Together, 
these five factors contribute to a critical cellular machine that is necessary to lengthen 
telomeric DNA in budding yeast.  However, despite intensive efforts, the precise 
functional contribution made by each factor to telomere maintenance still has not been 
entirely delineated.  
 An early model proposed a holoenzyme complex formed by the EST1-4 and TLC1 
gene-products, which was supported by an epistasis analysis showing no apparent 
enhanced telomere or senescence phenotypes upon combinatorial deletion of the various 
loci (Lendvay et al., 1996).  Biochemical studies in which telomerase activity was 
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isolated in an enriched extract along with additional genetic work indicated that Est2 and 
Tlc1 form the core telomerase enzyme with Est2 serving as a reverse transcriptase protein 
and Tlc1 as an RNA template (Singer and Gottschling, 1994; Counter et al., 1997; 
Lingner et al., 1997).  Coimmunoprecipitation experiments suggested that Est1 initiates 
formation of a minimal holoenzyme complex by directly binding to the Tlc1 RNA 
(Steiner et al., 1996; Zhou et al., 2000).  Further studies suggested an assembly pathway 
in which Est1 and Est2 bind directly to the Tlc1 RNA and Est3 joins the complex in an 
Est1-dependent manner and associates with the amino-terminus of Est2 (Hughes et al., 
2000; Livengood et al., 2002; Seto et al., 2002; Friedman et al., 2003; Osterhage et al., 
2006).  In the absence of Tlc1, stable biochemical interactions between Est1 and Est2 
were not apparent, although contact between Est1 and Est2 in the absence of Tlc1 can be 
detected using the chromatin immunoprecipitation assay in vivo (Evans and Lundblad, 
2002; Bianchi et al., 2004).  As free core telomerase (i.e., non-telomere bound) does not 
form a “precipitable” interaction with Cdc13, Cdc13 has not been considered a 
holoenzyme component (Hughes et al., 2000). Together, these studies indicated that Tlc1 
and the Est1-3 proteins form a nominal holoenzyme complex that stably exists 
independent of a DNA-bound telomere environment. 
 
The Role of Est1 and Cdc13 in Telomerase Function 
 Est1 and Cdc13 each have an in vitro ability to bind single-stranded G-rich DNA, 
which is representative of the chromosomal 3’ telomeric DNA overhangs (Nugent et al., 
1996; Vitra-Pearlman et al., 1996; Qi and Zakian, 2000).  Hence, it was suggested that 
Est1 and Cdc13 mediate telomerase recruitment to a telomere.  Supporting this notion 
was the capacity of Est1 and Cdc13 to interact directly, as shown by yeast two-hybrid and 
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coimmunoprecipitation assays (Nugent et al., 1996; Qi and Zakian, 2000).  Genetic 
studies solidified a now classic telomere model and introduced the concept that Est1 
might function as a bridging protein connecting telomerase to DNA-bound Cdc13 (Figure 
2) (Hughes et al., 2000; Nugent et al., 1996; Evans and Lundblad, 1999; Pennock et al., 
2001).  Perhaps, the most prominent contribution to the Est1 bridging model was the 
observation that est1 yeast do not display an EST phenotype if the cells express a 
Cdc13-Est2 fusion protein (Evans and Lundblad, 1999).  According to the model, Cdc13-
Est2 alleviated the need for Est1 since telomerase was now covalently attached to the 
primary telomeric DNA binding protein Cdc13.  Intriguingly, the fusion approach also 
demonstrated that Est1 serves a telomere role that is distinct from bridging.  If Est1 was 
expressed in conjunction with the Cdc13-Est2 fusion then the telomeric DNA was 
hyperelongated, which suggests Est1 up-regulated telomerase DNA extension activity 
when the enzyme was in stable association with Cdc13 at a telomere.   
 Further genetic evidence added to the concept that an interaction between Est1 
and Cdc13 was central for telomere DNA maintenance.  The first data indicating a 
connection was the demonstration that Est1 overexpression partially suppressed the 
telomere shortening and cellular senescence phenotypes observed in the cdc13-2 mutant 
background; (Nugent et al., 1996) the cdc13-2 mutation results in a single amino acid 
change (E252K).  Significantly, an est1 mutation (est1-60) was isolated that functions as 
a cdc13-2 suppressor and reestablishes near wild-type telomere maintenance and cell 
growth (Pennock et al., 2001).  The Est1-60 mutant contains a single altered residue 
(K444E).  The requirement of the 252/444 salt-bridge was confirmed with another 
derivative series (Cdc13-9 (E252R) and Est1-62 (K444D)) (Pennock et al., 2001).  With 
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the charge-swap nature of the Cdc13 and Est1 derivatives and phenotypic connections, 
the requirement of a physical link between Est1 and Cdc13 for telomere DNA 
maintenance was well established.  In general, the interaction was modeled as a bridging 
function even though the genetic data could also fit with roles in activation and/or 
stabilization.  To resolve the precise contributions made by each non-core EST protein 
(i.e., Est1, 3 and 4) would require more directed research. 
 The development of a telomere-specific chromatin immunoprecipitation (ChIP) 
protocol permitted a more mechanistic exploration of the timing and impact of select 
proteins on telomere complex assembly (Taggart et al., 2002).  Est1 and Est2 were both 
found at telomeres in late S-phase as expected since telomeric DNA is only lengthened at 
this point in the cell cycle (Taggart et al., 2002; Marcand et al., 2000).  Cdc13 is 
apparently telomere-associated throughout the cell cycle with an increased localization 
during late S-phase, which likely supports its roles in a number of functions including 
DNA-end protection and extension (Nugent et al., 1996).  Unexpectedly, Est2 but not 
Est1 localized to telomeres in G1 (Taggart et al., 2002).  Thus, Est1 is not requisite for 
telomere recruitment of telomerase.  Further studies showed that yKu70/80 brings 
telomerase to the telomere in G1 and also influences the S-phase complex by binding to a 
RNA stem-loop in Tlc1 (Stellwagen et al., 2003; Fisher et al., 2004).   
 Notably, the first ChIP telomere report demonstrated that both Est1 and Est2 
associate normally with telomeres in a cdc13-2 background (Taggart et al., 2002).  This 
result was in stark contrast to the genetic model predicting a requisite interaction between 
Cdc13 and Est1, through the 252/444 salt-bridge, for recruitment of telomerase to a 
telomere.  In follow-up work that utilized epitope variants of Est1 and Est2, reductions in 
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telomere interactions were detected in the cdc13-2 background (Chan et al., 2008).  
Though both ChIP studies employed myc-tagged version of Est1 and Est2, the second 
report incorporated a linker between the epitope-tag and the coding regions that 
presumably enhanced the sensitivity of the ChIP output (Taggart et al., 2002; Chan et al., 
2008).  However, in a separate report focusing on Est1, the Est1-60 mutant displayed a 
telomere association that was comparable to wild-type Est1 (Smith et al., 2003).  If Est1 
requires the 252/444 salt-bridge to interact with Cdc13 and be telomere associated, then 
no telomere binding should have been detected for Est1-60.  Collectively, the ChIP data 
demonstrates that the salt-bridge interaction between Est1 and Cdc13 is not requisite for 
nucleating holoenzyme components to a telomere.  However, the salt-bridge does appear 
to be essential for the healing of double-stranded breaks through the recruitment of 
telomerase activity (Bianchi et al., 2004).  If the Est1 Cdc13 interaction is not central for 
telomerase nucleation at a telomere then why is the salt-bridge critical for telomere DNA 
maintenance and how might telomerase be recruited to a telomere?  Thus, to better 
understand both the role of Hsp90 and Est1 with telomerase, an indepth biochemical 
analysis of each was necessary.  My thesis centers around using biochemical techniques 
to elucidate how both Hsp90 and Est1 function within the telomere maintenance 
pathway. 
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Figure 1. The complexity of the telomere maintenance pathway To effectively 
operate, the telomere system nucleates a number of different protein complexes to 
chromosomal ends on a cell cycle and need basis (Gilson and Geli, 2007).  In M 
phase, a telomere is in a capped, non-extendable state to prevent DNA damage and 
non-homologous end joining (i). Although the telomere remains non-extendable in 
G1, the complex is modified by the addition of the core telomerase subunits (ii).  In S 
phase the DNA replication machinery duplicates the DNA with the exception of the 
extreme 5’ terminus (iii).  Following replication, the DNA resectioning machinery 
degrades a section of the 5’ C-strand (iv).  In late S phase the telomere can transition 
to an extendable state by assembling the telomerase holoenzyme to lengthen the 3’ G-
strand (v).  In S/G2, the C-strand is filled in by the DNA polymerase a machinery and 
the telomere structure returns to a protective capping complex (vi).  The identities of 
the individual components or complexes are indicated.  Interactions between HSP90 
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Figure 2. Genetics suggest Est1 functions as a bridging factor to recruit 
telomerase to the telomere.  Prior studies have demonstrated that assembly of a 
telomerase holoenzyme initiates with Est1 and Est2 binding to the Tlc1 RNA and 
then the Est3 subunit enters.  These steps likely occur independent of a telomere 
environment.  Genetic analysis initially favored a “Classic” model for engaging the 
Est1-3 enzyme with telomeres.  In the Classic recruitment pathway the Est1-3 
enzyme loads onto a telomere by using the Est1 subunit as a bridging protein that 
connects telomerase to the telomere-bound Cdc13 protein (Nugent et al., 1996; Evans 
and Lundblad, 1999; Hughes et al., 2000).  The salt-linkage between Est1 and Cdc13, 
which is critical for telomere DNA maintenance (Pennock et al.,  2001), is necessary 
to form the Est1/Cdc13-bridge. 
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CHAPTER 2
*
 
HSP90  AND THE “CST” CAPPING COMPLEX AT THE TELOMERE 
 
 The Hsp90 molecular chaperone is a highly conserved and abundant protein that 
has evolved into an essential eukaryotic protein (Borkovich et al., 1989; Ghaemmaghami 
et al., 2003; Wegele et al., 2004). Given recent proteomic and genetic screens, Hsp90 has 
a role in a multitude of normal cellular functions and is involved in a number of diseases 
ranging from conformational protein folding problems to cancer (Richter et al., 2009).  
Accelerating the interest in Hsp90 is its developing use as a therapeutic target for diverse 
diseases (Power and Workman, 2006; Whitesell and Lindquist, 2005).  Presumably, the 
broad therapeutic spectrum results from Hsp90’s role in maintaining the conformation, 
stability and activity of many key cellular proteins that includes intracellular hormone 
receptors, cRaf, Her2, Akt, Cdk4, p53 and telomerase.  Despite its apparent central role in 
the eukaryotic molecular chaperone system and disease relevance, its mechanistic role in 
client protein regulation is not well understood.  In this chapter I investigate the yeast 
Hsp90 contributions to telomerase activities. 
 Telomerase maintains genomic integrity, in part, by preserving chromosome 
length following DNA replication (Cech, 2004; Smogorzewska and de Lange, 2004).  
Since conventional DNA polymerases require priming events to initiate synthesis, the 
                                                
*
 Data presented in this chapter were originally published in 1.) Toogun OA, DeZwaan 
DC and Freeman BC. (2008) The HSP90 molecular chaperone modulates multiple 
telomerase activities. Mol. Cell. Biol., 28:457-67.  2.) DeZwaan DC, Toogun OA, 
Echtenkamp FJ and Freeman BC. (2009) The Hsp82 molecular chaperone promotes a 
switch between unextendable and extendable telomere states. Nat. Struct. Mol. Biol., 
16:711-6.  I performed all of the presented experiments in this study.  
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extreme terminus of each lagging strand cannot be completed—commonly referred to as 
the end replication problem (Watson, 1972).  In the absence of a compensatory process, 
this limitation would lead to chromosome erosion with each round of replication.  Almost 
all eukaryotes circumvent this problem by adding a tandem array of simple sequence 
repeats to each terminus that buffers against the loss.  Depending upon the organism, 
telomerase increases chromosome ends between a few hundred to a few thousand 
nucleotides to create the telomeric DNA end (Smogorzewska and de Lange, 2004).  
Perhaps unexpectedly, it was realized that the length of each telomere is not added at 
once but rather telomerase typically appends 6-8 nucleotides per binding event (Prescott 
and Blackburn, 1997).  While it had been argued that telomerase might not need to be 
processive to maintain telomere length (Lundblad and Szostak, 1989), recent studies in 
yeast indicate that telomeres can be extended over 100 nucleotides per cell cycle 
(Marcand et al., 1999; Teixeira et al., 2004).  The mechanism(s) that govern the 
necessary repetitive telomerase-DNA binding and extension events are poorly 
understood. 
 The Hsp90 and p23 molecular chaperones were the first two telomerase cofactors 
found to alter DNA extension activity in vitro (Holt et al.,1999).  At the time it was 
suggested that these two chaperones serve to assemble the telomerase catalytic protein 
with its RNA template—telomerase is a specialized reverse transcriptase that uses an 
RNA moiety to specifically extend the 3’ DNA end (Smogorzewska and de Lange, 
2004).  However, recent reports indicate that Hsp90 and p23 can function after assembly.  
DNA extension by the mature telomerase enzyme is reduced upon Hsp90 inhibition 
(Keppler et al., 2006).  However, if a telomeric DNA substrate is added prior to the 
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Hsp90 inhibitor the effect is alleviated, which suggests Hsp90 supports telomerase DNA 
binding.  The yeast p23 homolog Sba1p, on the other hand, was shown to promote 
telomerase dissociation from DNA in vitro and affect telomere maintenance and 
telomerase telomere occupancy in vivo (Toogun et al., 2007).  Unfortunately, correlative 
in vivo roles for human Hsp90 have not been reported.   
 In contrast to the mammalian system, Hsp90-dependent changes to yeast 
telomerase activity in vitro have not been shown and effects on telomere length have 
been conflicting.  In one report, telomere length was unaltered upon disruption of either 
one of the two yeast Hsp90 genes HSP82 or HSC82; in addition, no telomere changes 
were observed in yeast expressing only low Hsp82p levels (~10% of normal) (Grandin 
and Charbonneau, 2001).  Yet in a systematic evaluation of ~4,800 haploid gene deletion 
strains, the hsc82 null was found to have shortened telomeres (Askree et al., 2004).  In an 
attempt to better understand the role(s) yeast Hsp90 proteins might have with telomerase 
I investigated Hsp82p-mediated effects on telomerase extension activities in vitro. 
 
Yeast telomere length is Hsp90-dependent 
 To address whether proper telomere maintenance is yeast Hsp90-dependent, a 
southern blot analysis was necessary.  While a telomere length defect might be more 
striking if the cellular yeast Hsp90 (i.e., Hsp82p and Hsc82p) activities could be 
completely eliminated, the essential nature of this protein family prohibits this test 
(Borkovich et al., 1989).  As a prior study indicates that even low Hsp82p levels are 
sufficient to support telomere length (Grandin and Charbonneau, 2001), an alternate 
tactic was used in which telomere length was assessed in the absence of any wild type 
 21
Hsp82 or Hsc82 protein.  To achieve this end point established engineered yeast strains 
were used, in which the endogenous HSP82 and HSC82 genes have been disrupted and 
viability is maintained by plasmid-born expression of either a wild type (HSC82 or 
HSP82) or a mutant allele (Nathan and Lindquist, 1995; Johnson et al., 2007; Toogun et 
al., 2008).  In general, both wild type Hsp82p or Hsc82p expression were sufficient for 
telomere DNA length maintenance, but when both wild type proteins were absent a wide 
telomere DNA phenotype distribution was observed in the 24 different alleles examined. 
The hsp82 G170D allele was found to display the most significant decline in telomere 
length (~50%) (Toogun et al., 2008). Hence, the hsp82/hsc82 allele-specific phenotypes 
indicate that a wild type yeast Hsp90 protein is required for proper telomere DNA length 
maintenance.   
 
Telomerase DNA extension activity is yeast Hsp90-dependent 
  To address whether the observed telomere shortening might arise from a 
telomerase activity defect I prepared standard telomerase DEAE extracts from various 
allelic backgrounds (Prescott and Blackburn, 1997).  In general, I found a reduced 
telomerase DNA extension activity in the mutant backgrounds (Figure 3A); the relative 
activity of each extract compared to the parental strain is provided.  As the extracts all 
contained equivalent telomerase levels (i.e., TLC1 amounts) (Figure 3A), the changes in 
the DNA extension activity likely result from the mutations in either Hsp82p or Hsc82p.  
With the exception of the S481Y and G309S backgrounds, I observed a good correlation 
between the relative DNA extension levels in vitro and telomere lengths in vivo (Toogun 
et al., 2008). Given the general correlation between the in vitro and in vivo defects, I 
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suggest that the primary supporting role for Hsp82p and Hsc82p at the telomere is with 
telomerase.  Importantly, titration of recombinant Hsp82p into the various extracts was 
sufficient to recover extension activity (Figure 3B); supplementation of a control protein 
(e.g., BSA) had no apparent effect (data not shown).  In addition to the general increase 
in DNA extension levels, Hsp82p supplementation promoted longer telomerase products 
as the pronounced pausing at the +2 position in the unsupplemented reactions was 
relieved (Figure 3B).  These data provide the first evidence that Hsp82p might modulate 
nucleotide processivity by telomerase.   
  To more directly assess whether Hsp82p has a role in telomerase nucleotide 
addition, I performed DNA extension assays under limiting concentrations of nucleotide.  
I reasoned if Hsp82p promotes telomerase nucleotide addition then the enzyme might 
display an increased reliance on nucleotide availability in the absence of a wild type 
Hsp90 chaperone.  In the assays, I exploited a telomeric DNA substrate terminating with 
TGG at the 3’ end.  Alignment of the TLC1 template and this substrate would permit 
incorporation of a single G nucleotide and then depending upon the availability of dTTP 
the complex would pause (Prescott and Blackburn, 1997).  As expected I observed a 
single extension product at +1 in the presence of only [
32
P ]a-dGTP using extracts 
prepared from either wild type, G170D or T101I yeast (Figure 4, lanes marked with a 
minus sign).  However, as dTTP is titrated into the reactions longer extensions are 
observed (Figure 4).  While the intensity of the +1 products varied between the wild type 
and both G170D and T101I extracts, I found that a ~4-fold higher level of dTTP was 
required for telomerase to add a T at the +2 position in the T101I and G170D extracts 
relative to WT (Toogun et al., 2008); the Km for nucleotide in the wild type extract was 
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found to be 797+/-56 nM where as it increased to 3314+/-347 nM in the T101I 
background.  Thus, telomerase nucleotide affinity is altered in the absence of wild type 
Hsp82p. 
 
Telomerase DNA binding is compromised in the G170D background 
  In addition to investigating telomerase nucleotide addition activity, our laboratory 
also examined whether Hsp82p has a role in assembling the telomerase DNA complex.  
A recent report has shown that human Hsp90 is required for human telomerase to 
effectively bind a telomeric DNA substrate (Keppler et al., 2006).  By exploiting the 
temperature sensitivity of the G170D yeast strain, fluorescence anisotropy on extracts 
prepared at either 30 °C or 37 °C found that only the 37°C G170D extract displayed a 
decreased DNA binding activity; the telomerase DNA binding affinity was reduced 5-
fold in the G170D background for a Kd of ~1 nM to ~5 nM (Toogun et al., 2008). 
Importantly, telomerase DNA binding in the G170D 37°C extract was recovered upon the 
addition of purified Hsp82p (Toogun et al., 2008).  These findings suggest that yeast 
Hsp90 supports at least two telomerase functions (DNA binding and extension) that are 
required for proper telomere maintenance. However, the affects of Hsp90 on telomere 
maintenance may not be limited to assisting in extension, as Hsp90 has also been 
implicated in affecting telomere capping components (Grandin and Charbonneau, 2001). 
 
Cdc13 stimulates telomerase DNA extension activity 
 Hsp82 and Hsc82 are high-copy suppressors for the capping mutants stn1-1 and 
cdc13-1 yet in a wild type background elevated chaperone levels result in shortened 
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telomeric DNA (Grandin and Charbonneau, 2001).  Neither the mechanism for the 
suppression nor the reduced telomere DNA length upon Hsp82-overexpression in wild 
type cells is understood.  Thus, it appears that Hsp90 chaperones affect both capping and 
extending telomere components though the mechanistic contributions to the capping 
factors had yet to be revealed.  
 As an initial step I determined the Cdc13 effect on telomerase DNA extension 
activity in vitro.  I anticipated that Cdc13 would inhibit telomerase function by competing 
for the DNA substrate, as observed for the human Cdc13 ortholog Pot1 (Kelleher et al., 
2005).  To discriminate Cdc13 DNA binding-dependent effects I used DNA substrates 
with either 23- or 7-nucleotide 3’-overhangs in the telomerase extension assays.  Prior 
biochemical studies indicated that Cdc13 requires a minimum of 11 single-stranded 
nucleotides to bind DNA (Mitton-Fry et al., 2004).  In accordance, I found that Cdc13 
protein only bound to DNA- overhangs of 11 bases or longer (Figure 5A).  Cdc13 was 
also unable to protect a short telomeric substrate (7 base overhang) from Exo-T nuclease 
activity, while it maintained a longer telomeric substrate (single stranded 30 base 
template) from degradation (Figure 5B).  Unexpectedly, Cdc13 activated telomerase 
DNA extension activity independent of 3’-overhang DNA length (Figure 6A and B).  The 
DNA products below the +1 position for the 23-base substrate are likely produced by a 
previously described telomerase-associated endonuclease activity (Niu et al., 2000).   
 Cdc13 enhanced the extension of the 23-base substrate to a greater extent relative 
to the 7-nucleotide 3’-overhang DNA (~18- vs. ~9-fold) suggesting that DNA binding by 
Cdc13 positively contributed to telomerase activity.  Nonetheless, the Cdc13 activation 
with a 7-base substrate suggested that Cdc13 could affect telomerase independent of 
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direct DNA binding. While stimulation by Cdc13 contrasts with the inhibitory effect of 
Pot1, it should be noted that Pot1 activates telomerase in conjunction with the telomeric 
protein Tpp1 (Wang et al., 2007).  Hence, Cdc13 apparently functions in a manner 
comparable to the combined effects of Pot1 and Tpp1. 
 
Cdc13, Stn1 and Ten1 form an unextendable telomere DNA Complex 
  In addition to Cdc13, Stn1 and Ten1 serve in telomere capping in vivo (Gilson 
and Geli, 2007).  To determine whether Cdc13 can function with Stn1 and Ten1, I 
purified the proteins (Figure 7), and tested the effects of the proteins on telomerase 
activity.  Ten1 alone caused inhibition of telomerase DNA-extension, while Stn1 alone 
activated telomerase DNA-extension on a 23-base 3’-overhang template (Figure 8).   
Cdc13 and Stn1 displayed a synergistic effect on telomerase DNA-extension, giving an 
increased activation state in comparison to either protein alone (Figure 8).  In the 
presence of Cdc13 I observed a striking reduction in DNA extension with increasing 
Stn1/Ten1 levels using the 23-base 3’-overhang (Figure 8).   
 Given the established Hsp82 roles with capping and extending telomere 
components, I tested whether Hsp82 might affect Cdc13.  As an initial test Hsp82 was 
titrated into DNA extension reactions containing a Cdc13/Stn1/Ten1-capped telomeric 
DNA substrate.  In the absence of Supplementary Hsp82, Cdc13/Stn1/Ten1 suppressed 
the DNA extension activity below basal levels.  However, in an Hsp82-dependent manner 
the extension activity increased, which indicates that Hsp82 is sufficient to switch the 
Cdc13/Stn1/Ten1-capping structure into a Cdc13/telomerase-extending complex (Figure 
9).  
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Discussion 
 The presented work has important implications for both our understanding of 
Hsp90 and telomerase.  In brief, yeast Hsp90 supports two telomerase functions (DNA 
binding and extension) that are required for proper telomere maintenance.  Initial studies 
linking Hsp90 and telomerase advocated that the chaperone helped assemble the reverse 
transcriptase protein with the RNA template to form the core telomerase enzyme (Holt et 
al., 1999). Notably, the presented data uniquely demonstrate that Hsp82p operates with 
an enzyme after DNA binding.  Perhaps the continued Hsp82p-association is required to 
maintain an open telomerase conformation that favors acceptance of free nucleotide and 
fosters the DNA extension activity.  The ability of Hsp82p to serve a DNA bound 
enzyme might be a general function, as Hsp90 proteins have been found associated with 
additional DNA enzymes including other reverse transcriptases and the DNA helicase 
XPB, which is required for transcription initiation and DNA repair  (Hu et al., 1997; Hu 
et al., 2004; Flom et al., 2005).   
 The multiple telomerase functions affected by Hsp82p parallels studies on the 
established Hsp90 client proteins steroid hormone receptors.  Initially, Hsp90 was found 
as a component of the 9S untransformed steroid receptors for glucocorticoids (GR) or 
progesterones (PR) in which Hsp90 was required to maintain the high affinity hormone 
binding state and prevent aggregation of the untransformed receptors (Bailly et al., 1978; 
Sanchez et al., 1987; Pratt, 1993).  In addition, Hsp90 was suggested to prevent DNA 
binding by the receptor through retention in the cytoplasm (Pratt, 1993).  However, recent 
studies refute this last hypothesis and indicate that Hsp90 is found in the nucleus and 
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facilitates rather than inhibits GR DNA binding (Stavreva et al., 2004).  In general, 
Hsp90 appears to support the DNA binding activities of heterologous transcription 
factors including p53, hypoxia-inducible factor 1 (HIF-1), aryl hydrocarbon receptor 
(AhR) and myogenic determination (MyoD) protein (Wilhelmsson et al., 1990; 
Shaknovich et al., 1992; Antonsson et al., 1995; Hur et al., 2004; Muller et al., 2004; 
Walerych et al., 2004).  Hence, Hsp90 maintains DNA binding proteins in a state able to 
respond to activation signals (e.g., phosphorylation or hormone binding) and furthers the 
various pathways by promoting the DNA bound complex. 
 The presented data in conjunction with a prior study on the yeast p23 molecular 
chaperone Sba1p (Toogun et al., 2007) suggest that the Hsp90 and p23 chaperones 
jointly modulate telomerase DNA binding.  In this model, Hsp82p and Sba1p cooperate 
to promote a rapid telomerase DNA binding cycle that would be highly beneficial for the 
addition of multiple telomeric DNA repeats during a single cell cycle—Hsp82p would 
promote assembly while Sba1p fosters disassembly.  The coordinated chaperone actions 
on telomerase also parallel an intracellular receptor paradigm (Freeman and Yamamoto, 
2001; Stavreva et al., 2004).  Given the divergent nature of telomerase and intracellular 
hormone receptors, the common functional effects mediated by Hsp90 and p23 
chaperones on these clients and recent proteomic studies, I suggest that these two 
molecular chaperones serve to maintain a wide variety of proteins in a dynamic state with 
DNA (Richter et al., 2007).  
 This work further provides a potential resolution to the apparent conundrum of 
how proteins with identical binding specificities coordinately function at a single site.  
Often DNA binding proteins form long-lived complexes with target DNAs in vitro that 
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would interfere with the assembly of other structures and telomere-protein assemblies are 
no exception (DeZwaan and Freeman, 2008).  For example, a stable Cdc13-telomere 
association at the extreme 3’ DNA end would block telomerase DNA binding yet Cdc13 
binding at the extreme termini likely is required to protect the DNA from degradation in 
vivo.  The data supports a model in which Hsp82 frees the DNA end of competing 
binding proteins without interfering with critical regulatory events.   
 In this model, telomerase recruitment to a telomere initiates through transient 
contacts between Cdc13 and the holoenzyme.  To permit proper telomerase DNA 
association Hsp82 displaces proteins bound at the extreme 3’ DNA end including Cdc13.  
Recent genetic studies highlight the potential importance of maintaining a dynamic 
telomere environment, as the peak of telomere association by Cdc13, Stn1 and Est1 all 
occur in S-phase (Puglisi et al.,  2008; Taggart et al., 2002).  Presumably, both capping 
(Stn1) and extending (Est1) proteins are telomere recruited each S-phase since not all 
telomeres are extended each cell cycle (Teixeira et al.,  2004).  Hence, depending upon 
the DNA length of a particular telomere a molecular choice is made to either permit or 
preclude telomerase function (i.e., build an Est1-extending or Stn1-capping complex).  If 
Hsp82 maintains Cdc13 in a dynamic DNA binding cycle, then any modifications (e.g., 
phosphorylation) meant to guide a telomere to a distinct operative phase would be 
immediately incorporated. 
 Recent genetic studies suggest post-translational modifications mediated by the 
Tel1 (ATM homolog) and Cdk1 kinases are critical for proper telomere DNA 
maintenance (Tseng et al., 2007; Li et al., 2009).  For example, Tel1 is recruited to 
critically short telomeric DNA tracts, which are preferentially elongated, and Cdc13 has 
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been shown to be a Tel1 target (Tseng et al., 2007; Arneric et al.,  2007).  In addition, 
Cdk1 phosphorylates Cdc13 and the modification appears to influence the preference 
between Stn1- and Est1-containing Cdc13 nucleated telomere complexes (Li et al.,  
2009).  Hence, depending upon the Cdc13 phosphorylation-state, telomeric DNA would 
be in a Cdc13-Stn1/Ten1 unextendable state or a Cdc13-Est1/telomerase extendable 
form.  Dynamic Cdc13 action, mediated by Hsp82, would enable the telomere system to 
rapidly transition between the different structures as needed. 
 Prior genetic data suggests a role for Cdc13 with telomerase that is downstream of 
telomere nucleation.  For example, the cdc13-4 yeast have short but stable telomeric 
DNA despite an apparent capacity of Cdc13-4 to recruit telomerase to telomeres and 
protect the DNA from degradation (Meier et al., 2001).  While the effected residue 
(P235S) occurs within the amino-terminal domain, the mechanism for the telomere defect 
was not identified.  However, the in vivo phenotype is consistent with a post-recruitment 
function for Cdc13 (Meier et al.,  2001).  Intriguingly, the Cdc13-109 and Cdc13-231 
mutants lead to over-elongated telomeric DNA despite a decline in DNA binding activity 
(Grandin et al., 2000).  If the sole positive function of Cdc13 was to recruit telomerase to 
a telomere, then a decline in DNA binding should result in shorter not longer telomeric 
DNA.  Additionally, the hyper-elongation of telomeric DNA in the cdc13-5 yeast is 
consistent with a post-recruitment role for Cdc13.  The Cdc13-5 protein (N-domain) 
consists of the amino-terminus and DNA binding domain (Chandra et al.,  2001).  In the 
absence of the Cdc13 carboxyl-terminal Stn1 interaction site the telomeric DNA should 
be vulnerable to nuclease attack.  Yet, the telomeric DNA is not degraded in the cdc13-5 
yeast but rather is over-elongated (Chandra et al.,  2001).  I suggest that, in addition to 
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recruiting telomerase, Cdc13-5 activates telomerase to not only hyper-extend the DNA 
but also to counter any potential DNA degradation.  Of note, the stimulatory function is 
downstream from Cdc13-mediated recruitment since the effect is abrogated when 
combined with the Cdc13 point mutation cdc13-2 (i.e., cdc13-2,5) (Chandra et al.,  
2001).  Taken together, established genetic data support the contention that Cdc13 
modulates the DNA-bound enzyme.  I suggest that telomerase cofactors, including 
Cdc13, likely reengage the telomere protein assembly by tethering to the DNA-bound 
telomerase enzyme.   
 A chaperone-mediated protein dynamics model has been previously proposed for 
transcription pathways (Freeman and Yamamoto, 2001).  In brief, molecular chaperones 
promote a dynamic action for transcription factors that is necessary to permit rapid 
functional recruitment of multiple coactivating complexes to a gene promoter.  An 
important distinction, however, is the impact of the Hsp90 chaperone: Hsp90 promotes 
DNA binding by transcription factors but facilitates dissociation of Cdc13-DNA 
complexes.  Perhaps the dual role for Hsp82 at telomeres provides an explanation for the 
difference.  By exploiting the telomerase-associated cofactor Hsp82 to both support 
telomerase function and to clear the telomeric DNA of competing proteins, an elegant 
means to ensure telomeric DNA extension within the short working period allotted 
telomerase at the end of S phase is provided.   
 Traditionally Hsp90 has been viewed as a cytoplasmic molecular chaperone 
required for the late folding stages of signaling molecules (Wegele et al.,  2004).  
However, recent studies including high-throughput screens have identified a broad-range 
of potential nuclear client proteins (DeZwaan and Freeman, 2008).  Given the impact of 
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Hsp90/Hsp82 both on telomeric and transcriptional targets, there appears to be a general 
cellular role for Hsp90 chaperones in controlling protein-DNA dynamics.  In brief, multi-
step pathways, including the telomere system, move forward through high affinity 
interactions between the low abundant proteins unique to that system (e.g., Cdc13, 
telomerase, Stn1) while proper structure composition (i.e., competitive interactions) 
along with efficient transitions between the different assemblies are mediated by 
transient, low affinity interactions with the highly abundant molecular chaperone 
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Figure 3.  Telomerase DNA extension activity is Hsp82p-dependent in vitro.  
Telomerase-mediated extension of an immobilized 7-base single-stranded 3’ overhang G-
rich DNA substrate was examined using conventional DEAE telomerase extracts 
prepared from yeast expressing the indicated hsc82 or hsp82 alleles.  (A.) The abilities of 
the indicated DEAE telomerase extracts to extend a telomeric DNA substrate in the 
presence of [a-
32
P] dGTP and dTTP was determined.  The extract prepared from the 
parental strain is HSC82 HSP82 and those from the hsp82 strains are clustered on the left 
(HSP82, T101I and G170D) while extracts made from the hsc82 strains are shown on the 
right (HSC82, W296A, S481Y, F345A and G309S).  The normalized percent DNA 
extension activities derived from 6 independent experiments for each extract is shown 
below each lane.  The northern blot analysis showing the relative TLC1 RNA levels in 
each extract is shown below the DNA extension data; TLC1 levels were also checked by 
reverse transcription real time PCR analysis (data not shown).  (B.) Purified Hsp82p was 
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(Figure 3 continued) sufficient to restore telomerase DNA extension activity in vitro.  
Recombinant, purified Hsp82p was titrated (0.2, 0.5, 1.0, 2.0, 4.0 mM) into the indicated 
telomerase extracts; endogenous cellular Hsp82p levels in yeast have been calculated to 
be ~17 mM (Picard, 2006).  The extracts were prepared from the parental HSC82 HSP82 
(WT), hsp82 allele (G170D or T101I) or hsc82 allele (G309S or F345A) strains.  All 
extension reactions contained equivalent levels of TLC1 RNA and a polynucleotide 
kinase end-labeled 27-base oligonucleotide was added prior to the precipitation of all the 
DNA extension products to serve as a loading control.  The resolved extension products 
were visualized using a Molecular Dynamics PhosphorImager. 
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Figure 4. Hsp82p affects telomerase nucleotide affinity.  The dTTP concentration 
needed for telomerase nucleotide addition in the presence and absence of wild type 
Hsp82p was determined using a dTTP titration.  Telomerase extracts prepared from either 
yeast expressing wild type HSP82 or the G170D and T101I alleles were incubated with 
[a-
32
P] dGTP, 7-base 3’-overhang DNA substrate and various amounts of dTTP (0, 0.25, 
0.5, 1, 2, 4, 8, 16, 32 or 64 μM). 
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Figure 5. Cdc13 has the ability to associate with single-stranded DNA. (A.) Cdc13 
needs at least 11 bases of single stranded DNA to form a complex. Electro-mobility shift 
assays were used to test the ability of Cdc13 to bind a series of single-stranded 
oligonucleotides (250pM). Template length ranged from 9 bases to 17 bases.  (B.) Cdc13 
protects the DNA end from nuclease digestion. Radio-labeled 30-nucleotide single-
stranded telomeric (ss-30mer) DNA (250 pM) or hybrid single/double-stranded DNA 
substrates (250 pM) with either 21- or 7-base 3’-overhangs were treated with Exo-T 
nuclease alone or after incubation (2 min at room temperature) with full-length Cdc13 (C; 
100 nM). All three substrates use the radio-labeled 30-nucleotide single-stranded DNA. 
The hybrid 3’-overhang substrates are formed with oligonucleotides complimentary to 
the 5’ end of the 30-nucleotide single-stranded DNA (see Material and Methods). 
Following nuclease addition the reactions were incubated 12 min at 30°C, the reactions 
were stopped by the addition of formamide/NaOH loading buffer and boiling for 5 min, 
the samples were resolved on a 12% denaturing polyacrylamide gel, the polyacrylamide 
gel was dried and the products were visualized with a PhosphoImager. The 7-base 3’-
overhang substrate likely displays no apparent protection by full-length Cdc13 since it is 
not bound by Cdc13. 
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Figure 6.  Cdc13 stimulates telomerase DNA extension activity independent of 
single-stranded 3’-overhang DNA length.  The Cdc13 effect on telomerase-mediated 
DNA extension was determined using DNA substrates with either (A.) 7-or (B.) 23-
nucleotide 3’-overhangs and a Cdc13 protein titration (50, 100, 250, 500 and 1000 nM), 
as marked.  To control for possible non-specific protein affects the impact of BSA 
addition was tested.  All extension reactions were supplemented with a loading control 
primer (arrow) prior to precipitation and electrophoretic resolution and the +1 position for 
each DNA substrates is marked. 
 
 
 
 
 
 
 
 
 37
 
 
 
 
 
 
 
 
 
 
Figure 7. Purification of the “Capping” proteins. Recombinant purified 
(1 μg) ~103KDa Cdc13 full-length (C), 55KDa Stn1 (S) and 18KDa Ten1 (T) were 
resolved on a 12% SDS-PAGE and stained with Coomassie Blue. 
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Figure 8.  Stn1 and Ten1 cooperate with Cdc13 to form an unextendable telomere 
protein-DNA complex in vitro.  The effect of  a Ten1 protein titration (100, 250, 500, 
1000, 2500 and 5000 nM) on telomerase DNA extension in the presence or absence of 
Cdc13 (50nM) and/or Stn1 (100nM) was determined using 23-base 3’-overhang DNA.  
For comparison, the activity of unsupplemented, Cdc13 supplemented and Stn1 
supplemented telomerase extract is shown. 
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Figure 9.  Hsp82 promotes the conversion of the Cdc13-capping structure into a 
Cdc13-extending complex.  The ability of Hsp82 to convert an unextendable 
Cdc13/Stn1/Ten1-capped DNA complex into a telomerase accessible DNA structure was 
determined using a 23-base 3’-overhang DNA substrate, telomerase extract and an Hsp82 
protein titration (0.25, 0.5, 1.0, 2.5, 5.9, 10.0 and 20.0 μM).  The cellular Hsp82 
concentration is 17μM (Picard, 2006). 
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CHAPTER 3
*
 
BIOCHEMICAL CHARACTERIZATION OF EST1 
 
 Telomeres are nucleoprotein complexes found at chromosome ends that maintain 
DNA termini at an appropriate length to preserve genome stability and cell viability 
(Gilson and Geli, 2007).  Most eukaryotes use the telomerase enzyme to sustain telomeric 
DNA.  The telomerase core enzyme is comprised of a reverse transcriptase (Est2 in yeast) 
and an RNA template (TLC1) and the yeast holoenzyme includes the Est1 and Est3 
cofactors.  EST1 was the first protein-encoding gene identified that was speculated to be a 
telomerase component, as est1 cells display the ever shorter telomere phenotype 
(Lundblad and Szostak, 1993).  While Est1 is an established telomerase cofactor, its 
direct mechanistic contribution to telomerase activity had not been understood. 
 Genetic experiments suggest two potential Est1 roles with telomerase, as a 
bridging factor (Figure 2) coupling telomerase to the telomeric DNA binding protein 
Cdc13 during telomere recruitment and as an activator for telomerase enzymatic activity 
once the holoenzyme is telomere-bound.  A seminal study, which exploited protein 
fusions between Est1, Cdc13 or telomerase, suggested an Est1 activation function since 
telomeric DNA is hyper-elongated in an Est1-dependent manner upon expression of a 
Cdc13-Est2 fusion protein (Evans and Lundblad, 1999).  In addition, it was shown that 
covalent linkage of normally deleterious Est1 or Cdc13 mutants abrogates telomere 
defects implying that the mutations affect recruitment.  Supporting a requisite Est1-
                                                
*
 Data presented in this chapter were originally published in DeZwaan DC and Freeman 
BC. (2009) The conserved Est1 protein stimulates telomerase DNA extension activity. 
Proc. Natl. Acad. Sci. USA., 106:17337-42.  I performed all of the presented experiments 
in this study. 
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Cdc13 interaction for proper telomerase regulation are reciprocal-charge mutants (e.g., 
est1-60 (K444E) suppresses cdc13-2 (E252K)) that separately lead to telomere DNA 
shortening (Pennock et al., 2001).  Since Est1-60 can bind telomerase in vivo, it was 
proposed that the K444E mutation disrupts Cdc13 association (Pennock et al., 2001; 
Bianchi and Shore, 2004).  However, other studies suggest that the Cdc13-2 mutation 
does not disrupt Est1 interactions since wild-type Est1 interacts with Cdc13 and Cdc13-2 
in vivo (Qi and Zakian, 2000; Taggart et al., 2002; Chan et al., 2008).  Although in the 
absence of a direct biochemical assessment it is difficult to delineate the mechanistic 
effects of the various Est1 and Cdc13 mutations.  
 To modulate telomerase it has been speculated that Est1 relies on its two known 
activities, DNA and RNA binding.  Prior biochemical studies demonstrate that yeast and 
human Est1 bind single-stranded G-rich DNA and apparently recognize RNA non-
specifically in vitro (Vitra-Pearlman et al., 1996; Snow et al., 2003; Redon et al., 2007).  
In contrast to the in vitro work, in vivo studies indicate that yeast Est1 targets a bulged-
stem loop in the TLC1 telomerase RNA (Livengood et al., 2002; Seto et al., 2002).  The 
Est1-TLC1 interaction appears to be direct since it occurs in the absence of the Est2 
protein in vivo (Steiner et al., 1996).  Despite these reports, it was not apparent how Est1 
modulates telomerase.  I have attempted to understand the Est1 regulatory mechanism by 
investigating: 1) the Est1 impact on telomerase DNA extension activity; 2) the necessity 
of the TLC1 bulged-stem loop for Est1 RNA binding; 3) the Est1 DNA binding 
determinants; 4) the influence of Est1 nucleic acid binding on telomerase regulation; 5) 
the activities of various Est1 point mutants. 
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Est1 activates telomerase DNA extension activity 
 To study the mechanism of Est1 action the protein was purified to near 
homogeneity (Figure 10A and B).  As an initial functional test, I titrated the Est1 protein 
into telomerase DNA extension reactions.  I found that Est1 stimulated activity ~14-fold 
using telomerase extracts prepared from either est1 or parental cells (Figure 10C).  As 
the DNA banding pattern is not reproducibly altered (e.g., enhancement of longer 
products) upon Est1 addition but rather the relative product intensities are elevated, I 
suggest that Est1 increases the percent of active enzyme.  Based upon the activation 
potential, Est1 displayed a high affinity for telomerase (Kd 3.5+/-1 nM in est1 and 27+/-
4 nM in wild-type telomerase extract).  The variance in Est1-telomerase affinities might 
result from the presence of Est1 protein, albeit limiting, within the telomerase extracts or 
from a telomerase structural difference.  I suspect telomerase produced in the absence of 
Est1 is in a distinct conformation since the Est1 stimulatory effect is comparable using 
either wild-type and est1 telomerase extracts and even limiting Est1 amounts would 
diminish the fold-increase over the unsupplemented DNA extension activity.  To 
understand the Est1-mechanism employed to modulate telomerase I examined the impact 
of Est1 properties on the stimulatory effect. 
 
Est1 selectively binds to the TLC1 RNA bulged-stem loop 
 It has been suggested that a central bulged-stem loop within the TLC1 RNA is 
critical for telomerase regulation by Est1 (Livengood et al., 2002; Seto et al., 2002).  
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Therefore, I generated the Est1-TLC1 RNA binding site (bulged-stem loop fragment) and 
examined Est1 binding in vitro (Figure 11A).  By electro-mobility shift analysis (EMSA) 
Est1 displayed a relatively high affinity for the bulged-stem loop RNA (Kd ~40 nM), 
albeit lower than its affinity for telomerase (Figure 10).  The variation in RNA affinity 
relative to a prior report likely reflects the use of different RNA probes (Vitra-Pearlman 
et al., 1996).  The Est1 RNA binding was dependent upon the bulged-stem loop structure, 
as a disrupted-stem RNA displayed no apparent interaction and a bulge-delete RNA had a 
decreased affinity (Kd ~300 nM).  TLC1 RNA with compensatory mutations to 
reestablish the stem structure partially recovered the binding affinity (Kd ~150 nM) 
(Figure 11B).  Thus, Est1 is dependent upon the bulged-stem loop structure to bind to the 
central TLC1 region and the in vitro binding determinants correlate well with prior in 
vivo studies (Seto et al., 2002). 
 The role of the TLC1 bulged-stem loop in conducting Est1 telomerase activation 
was determined by titrating Est1 protein into extension reactions with telomerase extracts 
prepared from yeast expressing full-length wild-type, stem-disrupt, bulge-delete or stem-
compensatory TLC1 RNAs (Seto et al., 2002).  The affect of the various RNA mutations 
on telomere length were initially established by southern blotting (Figure 12A).  
Telomere shortening was observed in both the bulge deletion and stem disruption 
mutants, while the stem compensatory mutant had telomere lengths comparable to 
wildtype TLC1 samples (Figure 12A).  Unexpectedly, Est1 comparably activated the 
telomerase TLC1 derivatives (Figure 12B).  Although the stem-disrupt telomerase 
displayed an ~2-fold Est1 affinity decrease, the effect is mild relative to the decline in 
binding to the stem-disrupt TLC1 RNA binding (Figure 11B).  Based on these 
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differences, I suggest that the bulged-stem loop is one determinant in telomerase 
association but that other, likely protein-protein interactions between Est1 and Est2, are 
important for controlling telomerase activity. 
 
Est1 binds single-stranded telomeric DNA 
 The initial Est1 biochemical characterization demonstrated that the protein 
preferentially binds DNAs with 3’ single-stranded G-rich sequence (Vitra-Pearlman et 
al.,1996).  I wished to extend these observations by delineating the DNA length 
requirements for Est1 binding.  As an initial substrate I examined Est1 interactions with a 
30-base, single-stranded G-rich oligonucleotide by EMSA and found that Est1 bound 
with an apparent Kd ~75 nM (Figure 13); no binding was observed using a C-rich 30-base 
primer (data not shown).  Utilizing a series of single-stranded G-rich primers that varied 
from 15- to 30-bases I determined a minimal length requirement between 18 and 22 
nucleotides for binding to a fully single-stranded DNA (Figure 14A). 
 I also tested the single-stranded DNA length requisite using a hybrid DNA 
substrate comprised of a single-stranded 3’ end and a double-stranded 5’ section.  I found 
that Est1 bound well to 22- and 15-base 3’-overhang substrates but was unable to bind to 
shorter 3’-overhangs (Figure 14B).  The ability of Est1 to bind hybrid DNAs with a 15-
nucleotide overhang suggests that double-stranded DNA can be tolerated at the 5’ end.  
Hence, depending upon the nature of the substrate (i.e., fully single-stranded or hybrid) 
Est1 varied slightly in its DNA length requirements but still required single-stranded 
DNA for binding. 
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 Next, I determined whether Est1 might bind RNA and DNA simultaneously, as a 
prior report had indicated (Vitra-Pearlman et al., 1996).  I added Est1 to reactions 
containing a radiolabeled DNA probe alone or with increasing amounts of unlabeled 
TLC1 RNA (Figure 15).  If Est1 can concurrently bind DNA and RNA then a higher 
order, slower migrating complex would be expected; however, if binding were 
competitive then a decline in the Est1-DNA complex signal should occur.  Since the 
Est1-DNA signal decreased with increasing TLC1 RNA levels (Figure 15), Est1 DNA 
and RNA binding is mutually exclusive.  Contrary to the efficient competitive ability of 
TLC1 RNA for Est1 DNA interactions, I found that DNA competed ineffectively for 
RNA binding (data not shown).  While the differential competition outcomes were 
unanticipated given the comparable Est1 binding affinities for RNA and DNA, the 
observed results likely show that TLC1 RNA is the preferred Est1 substrate.  Minimally, 
my data indicate that telomerase regulation by Est1 involves only one bound nucleic acid. 
 
Est1 telomerase activation is independent of Est1 DNA binding 
 To address whether Est1 exploits single-stranded DNA to effect telomerase action 
I performed extension assays using DNAs with relatively short or long single-stranded 
lengths.  I found that Est1 equivalently up-regulated telomerase extension activity using 
substrates with 3’-overhangs of 7- to 24-nucleotides (Figure 16A).  Importantly, the basal 
and Est1-stimulated DNA extension products from either substrate were telomerase-
dependent since RNaseA treatment abolished activity (data not shown) (Prescott and 
Blackburn, 1997).  The products below the +1 position for each DNA substrate are likely 
produced by a previously described telomerase-associated endonuclease activity (Niu et 
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al., 2000).  Given the minimum 15-base requirement for Est1 DNA binding, it is unlikely 
that Est1 associates with the DNA during telomerase-mediated DNA lengthening.   
 To directly test whether Est1-DNA interactions influence telomerase regulation 
before assembly with telomeric DNA I performed order of addition experiments (Figure 
16B).  I preincubated Est1 or BSA with the DNA before adding telomerase (B), or 
telomerase with the DNA before adding the Est1/BSA (A).  The reactions were initiated 
upon addition of the third component and free nucleotide.  For the reactions where 
telomerase was preincubated with the DNA substrate, the immobilized DNA-bound 
complexes were washed to remove any unbound telomerase before initiating the 
reactions.  Of note, similar reactions were performed with the 23-base DNA substrate 
where the DNA-bound complexes were washed to remove any unbound 
Est1/BSA/telomerase before initiating the reactions and comparable stimulatory effects 
were observed (data not shown).  Since Est1 stimulated the DNA extension activity 
equivalently before or after telomerase DNA assembly, I suggest that Est1 tethers to 
DNA-bound telomerase and modulates the enzymatic activity independent of direct DNA 
binding by Est1. 
 
Est1 point mutants display differential activities 
 Genetic analysis has generated a large Est1 point mutant collection that have been 
speculated to affect telomere maintenance by a number of means including altered Cdc13 
association, defective TLC1 RNA interactions or declined telomeric DNA binding 
(Pennock et al., 2001; Evans and Lundblad, 2002).  In an attempt to better understand 
Est1 function, I have purified and characterized a select set including Est1-38, Est1-41, 
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Est1-42, Est1-49, Est1-50 and Est1-60.  Prior in vivo analysis showed that Est1-38, Est1-
41 and Est1-42 have lowered telomerase interactions but only altered telomeric DNA 
length slightly, Est1-49 and Est1-50 on the other hand displayed near wild-type 
telomerase binding but shortened telomeric DNA and Est1-60 does not support telomere 
DNA maintenance as it has been speculated to no longer interact with Cdc13 (Pennock et 
al., 2001; Evans and Lundblad, 2002). 
 I found that Est1-38, Est1-42, Est1-49 and Est1-50 had decreased RNA binding 
(~30, 62, 39 and 30% of wild type) and that Est1-38 and Est1-50 had declined DNA 
binding (~25 and 43% of wild type) and whereas the remaining mutants were 
functionally comparable to wild-type Est1 for nucleic acid interactions (Figure 17A and 
B).  Notably, Est1-38, Est1-49 and Est1-50 comparably stimulated telomerase activity 
relative to wild-type Est1 (Figure 17C).  In contrast, Est1-60 and Est1-41 had decreased 
(~34% and 38% of wild type, respectively) abilities to activate telomerase (Figure 17C); 
yet, neither showed an apparent nucleic acid binding defect.  Thus, in agreement with the 
wild-type protein data, Est1 nucleic acid binding and telomerase activation potentials are 
non-correlative. 
 Since RNA and DNA binding did not have a significant influence on telomerase 
regulation by Est1 I suspected a direct protein-protein interaction between Est1 and Est2 
was required.  To determine if Est1 can interact with Est2 independent of TLC1 RNA, I 
synthesized Est2 using rabbit reticulolysate in the absence of TLC1 RNA.  The Est2 
protein was produced as an amino-terminal Protein A fusion protein to allow isolation 
with IgG sepharose (Zappulla et al., 2005).  I found that Est1 can interact with Est2 
independent of Tlc1 RNA (Figure 17D).  The data agree with prior in vivo studies 
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showing that Est1 and Est2 interact in a tlc1 null background and that human Est1A 
associates directly with the reverse transcriptase subunit in vitro (Bianchi et al., 2004; 
Redon et al., 2007).  However, the interaction is less efficient in the absence of Tlc1, 
which suggests that the Tlc1 RNA fosters assembly of the complex, as has been 
previously suggested (Livengood et al., 2002; Seto et al., 2002).   
 Next, I examined the interaction patterns for wild-type Est1, Est1-60 or Est1-41 
(Figure 17D).  I did not observe a significant change in association between the Est1 
derivatives and Est2 alone.  If, however, I synthesized the Est2 in the presence of TLC1 
and then performed the pull-down I observed an enhanced Est1-60 association (~2.5-fold 
increase) and a declined Est1-41 interaction (~40%) relative to wild-type Est1 (Figure 
17E).  The reduced telomerase association by Est1-41 is comparable to the decreased in 
vivo interactions previously observed for Est1-41 and telomerase (Evans and Lundblad, 
2002).  Since neither Est1 mutant displayed an inherent RNA binding defect (Figure 17), 
I suggest that TLC1 binding has an allosteric effect on either or both Est1 and Est2, 
which alters Est1 interactions with the core enzyme.   
 To determine the relative telomere occupancy levels of Est1, Est1-41 and Est1-60 
in vivo a chromatin immunoprecipitation assay was employed (DeZwaan and Freeman, 
2009).  A similar telomere interaction pattern was found for the Est1 derivatives as 
observed for RNA binding—Est1-41 levels were reduced but Est1-60 and wild-type Est1 
occupancies were comparable (DeZwaan and Freeman, 2009).  While the in vitro and in 
vivo data are consistent, the Est1-60 telomere binding was unexpected since prior genetic 
work predicted that Est1-60 (K444E) would not associate due to a disrupted salt-bridge 
interaction with Cdc13 (Pennock et al., 2001).  Based upon the presented data, I suggest 
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that the reported telomeric DNA shortening in the est1-60 yeast involves a defect in 
telomerase stimulation, in addition to a perturbed interaction between Cdc13 and Est1 
that is essential for proper telomerase function at a telomere.  To understand if the Est1-
60 mutation affects functional interactions involving Cdc13 and telomerase our 
laboratory investigated the combinatorial effects of Est1 and Cdc13 on telomerase DNA 
extension activity. 
 Prior genetic work showed that the telomere DNA length defect in the est1-60 
background is alleviated by the second-site suppressor mutation cdc13-2 (Pennock et al., 
2001).  Therefore, if the inability of Est1-60 to fully stimulate telomerase in vitro is 
related to the in vivo telomere phenotype then inclusion of the Cdc13-2 mutant should 
reestablish proper telomerase up-regulation with Est1-60 in vitro.  To determine whether 
interactions between Est1 and Cdc13 impact telomerase our laboratory tested the 
individual and combined effects of purified Est1 and Cdc13 proteins on telomerase DNA 
extension activity in vitro.  Of note, it was found that Cdc13 was capable of stimulating 
telomerase DNA extension activity independent of Est1 and I have followed this 
observation in a separate study (DeZwaan et al., 2009).  The combination of Est1 and 
Cdc13 led to up-regulation of telomerase isolated from wild-type yeast (DeZwaan and 
Freeman, 2009).  While the cellular level of Est1 (a telomerase holoenzyme subunit) has 
not been determined, if we assume an amount comparable to the TLC1 RNA core subunit 
than the Est1 cellular concentration would be in the lower nanomolar range (Modzy and 
Cech, 2006).  Significantly, the combinatorial Est1-Cdc13 effect was not apparent when 
one of the wild-type proteins was substituted with a mutant derivative.  Yet, in the 
presence of both Est1-60 and Cdc13-2 telomerase activation was apparent (DeZwaan and 
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Freeman, 2009).  Since the combinatorial Est1-Cdc13 effect was apparent using either a 
short (7-base) or long (23-base) 3’-overhang substrate, I suggest that DNA binding by 
Est1 and Cdc13 is not imperative to stimulate the DNA-bound telomerase enzyme.  
Hence, in a manner paralleling the in vivo phenotypes the Est1-60 and Cdc13-2 mutants 
compensate and reestablish activity comparable to the wild-type condition.  While the 
interaction between Est1 and Cdc13 might influence a number of telomere events, our 
data demonstrate that the association is minimally required to properly control the 
enzymatic function of telomerase. 
 
Discussion 
 Est1 is a fundamental telomere DNA maintenance factor that is conserved from 
yeast to human (Snow et al., 2003; Reichenbach et al., 2003).  Genetic experiments in 
yeast have suggested an Est1-role in both recruiting and activating telomerase (Evans and 
Lundblad, 1999).  Yet evidence demonstrating a direct Est1 regulatory function with 
telomerase had been lacking.  Here I show that purified Est1 protein stimulates 
telomerase DNA extension activity in vitro, which parallels recent work with the human 
factors (Redon et al., 2007).  However, in contrast to prior suggestions, the direct Est1 
regulatory mechanism does not significantly rely on either telomeric DNA or TLC1 RNA 
binding. 
 While Est1 TLC1 interactions are dependent upon the bulged-stem loop structure 
both in vitro and in vivo  (Figure 11B; Livengood et al., 2002; Seto et al.,  2002) 
alteration of the bulged-stem loop only had a minor effect on telomerase stimulation in 
vitro suggesting Est1 recognizes TLC1 but the association is not a major activation-
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determinant.  Given the requisite for the TLC1 bulged-stem loop for telomerase binding 
in vivo, why isn’t there a more significant effect in vitro?  Perhaps the RNA interaction 
has an important role during telomerase holoenzyme assembly that is essential for 
efficient telomerase action in vivo but is dispensable in vitro.  Presumably holoenzyme 
assembly is required for efficient telomere-recruitment in vivo; the presented in vitro 
assays likely are not impacted by recruitment events.  The Est1 association with TLC1 
RNA in the absence of the Est2 protein indicates that the Est1-TLC1 interaction might 
represent the first step in holoenzyme assembly in vivo (Steiner et al., 1996). 
 In addition to RNA interactions, it has been suggested that single-stranded DNA 
binding by Est1 might contribute to telomerase modulation (Vitra-Pearlman et al.,1996).  
However, Est1 does not appear to rely on DNA interactions to affect telomerase in vitro 
(Figure 16).  Perhaps the Est1 DNA binding ability provides a means to telomere-
associate independent of telomerase but once telomerase arrives Est1 switches ligands 
and binds to TLC1—comparable DNA/RNA swapping has been previously postulated 
for other factors (Suswam et al., 2005).  Although the necessity of the Replication Protein 
A (RPA) for Est1 telomere loading suggests Est1 DNA binding activity is insufficient for 
telomere interactions (Schramke et al., 2004).  Alternatively Est1 DNA binding might be 
important for other non-telomeric cellular functions. 
 In my telomerase regulatory model, Est1 joins the core enzyme by selectively 
binding the TLC1 bulged-stem RNA loop—assembly of the holoenzyme prior to 
telomere association is requisite for downstream control events including telomerase up-
regulation (Livengood et al., 2002; Seto et al., 2002; Chan et al., 2008).  Once the 
holoenzyme engages telomeric DNA the contacts between Est1 and Est2 are critical for 
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efficacious telomerase DNA extension activity.  In addition to Est1, telomerase 
regulation in vivo requires Cdc13—minimally interactions between Est1 and Cdc13 are 
used to modulate the holoenzyme.  Though it had been suggested that a salt-bridge 
linkage between Est1 and Cdc13 is required for Est1 nucleation at a telomere, it appears 
that this is not the case.  Prior studies had interpreted the telomeric DNA shortening in 
the est1-60 background as an inability to recruit Est1 to the telomere and the phenotype 
suppression in est1-60 cdc13-2 yeast further supported this notion (Pennock et al., 2001).  
However, the Est1-60 protein displayed no apparent telomere recruitment defect (Figure 
17).  In conjunction with previous reports showing that Est1 interacts at telomeres in both 
wild-type and cdc13-2 yeast (Taggart et al., 2002; Chan et al., 2008), the necessity for the 
Est1(K444)-Cdc13(E252) salt-bridge for Est1 telomere recruitment is unlikely.  While 
interactions between Est1 and Cdc13 might be essential for stabilizing telomerase at a 
telomere in vivo, our studies have not addressed this potential function. 
 Minimally, the Est1-Cdc13 salt-bridge is important for regulating telomerase 
enzymatic activity.  While the absolute Est1 requisite for telomere DNA maintenance in 
vivo can be bypassed using a Cdc13-Est2 fusion protein, the significant reduction in 
telomeric DNA lengthening upon est1 deletion in the Cdc13-Est2 fusion background 
supports an Est1 role independent of telomere recruitment (Evans and Lundblad, 1999).  
The covalent linkage between the telomerase Est2 protein subunit and Cdc13 likely 
bypasses any potential telomere stabilization role by Est1.  The inability of Est1-60 to 
stimulate telomerase in vitro despite its capacity to interact with Est2 suggests that the 
mutant does not properly shift telomerase to a stimulated state (Figure 17).  Perhaps in 
the presence of the Cdc13-2 protein, which suppresses the Est1-60 defect, the 
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conformational switch in telomerase occurs.  I suggest the cdc13-2 and est1-60 mutations 
separately interfere with a critical contact point between the two proteins that is necessary 
for telomerase stimulation and for potentially stabilizing telomerase to a telomere.  
Presumably, in the presence of both protein mutants the charge-swap reestablishes the 
Est1-Cdc13 interaction and permits proper telomerase control.  Further studies will be 
necessary to delineate the potential structural changes that occur within the various 
telomere-binding proteins to mediate these regulatory steps.  Nevertheless, the presented 
data provide a novel understanding of Est1-telomerase control. 
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Figure 10.  Purified Est1 enhances telomerase DNA extension activity in vitro.  (A.) 
Recombinant Est1 (1 mg) was resolved on a 12% SDS-PAGE and stained with 
Coomassie Blue. (B.) The identity of the Est1 protein was confirmed by mass 
spectrometry analysis. The masses of peptides produced by the tryptic digestion of 
soluble Est1 protein were measured by MALDI TOF/TOF mass spectrometry. The amino 
acid Est1 sequence is shown with all of the identified peptides highlighted in red. For an 
example of the raw data please see 
file:///Users/bfreeman/Documents/Microsoft%20User%20Data/Saved%20Attachments/F
reeman%203–1-2007.htm. (C.) The Est1 effect on telomerase-mediated DNA extension 
was tested using extracts prepared from est1D yeast with an immobilized 7-base 3’-
overhang DNA substrate.  The DNA extension reactions were supplemented with BSA or 
Est1 (1, 2.5, 5, 10, 25, 50 nM), as marked.  To serve as a loading control an end-labeled 
27-base primer was added prior to precipitation of the extension products.  The positions 
of the loading control primer and +1 extension product are marked.  
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Figure 11.  Est1 RNA binding is dependent upon the central TLC1 bulged-stem 
loop.  (A.) To assess the Est1 RNA binding activity EMSA was used in conjunction with 
a radiolabeled TLC1 RNA probe.  To measure the interaction affinity between Est1 and 
TLC1 the wild-type bulged-stem loop RNA (250 pM) was incubated alone or with 
varying Est1 concentrations (30, 60, 120, 240, 480, 960, 1440 nM).  All binding reactions 
were resolved by native polyacrylamide electrophoresis.  The arrows mark free probe 
locations.  (B.) The Est1 RNA binding specificity was determined using established 
TLC1 RNAs that included stem disruption, bulge deletion and stem compensatory 
mutants (Seto et al., 2002).  The slower migration for the stem-disruption RNA indicates 
that it is in a distinct conformation.  The ability of Est1 (480 nM) to bind to each TLC1 
derivative (250 pM) was determined by RNA EMSA.  The asterisk marks the position of 
a minor slower migrating, distinctly folded RNA that occurs with the stem disrupt RNA.  
Though the migration of minor species reproducibly slows further following incubation 
with Est1, the change in migration is not dependent upon a stable Est1 interaction as it is 
apparent even after degradation of the Est1 following protease addition (data not shown).  
Hence, the slight migration shift in the minor RNA species present in the stem disrupt 
experiment does not result from a stable association with Est1.   
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Figure 12. Est1 does not use its RNA-binding ability to enhance telomerase 
extension. (A.) The affects that the TLC1 mutants have on telomere length were tested 
by southern blotting. Lane 1.) Wildtype, 2.) Bulge Delete, 3.) Stem Compensatory and 4.) 
Stem Disruption.  The arrow marks a “Cech Chromosome IV” probe used as a migration 
control, displaying that the changed migration was due to telomere shortening and not a 
whole chromosome problem. (B.) The Est1 effect on telomerase enzymes with the full-
length TLC1 bulged-stem loop derivatives was tested using in vitro DNA extension 
assays and a 7-base 3’-overhang DNA substrate.  Reactions were supplemented with 
increasing Est1 amounts (1, 10, 100 or 200 nM), as designated. 
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Figure 13. Est1 binds single-stranded G-rich DNA in a DNA length-dependent 
manner. The Est1 binding affinity for single-stranded G-rich DNA was determined by 
EMSA. The binding reactions contained a PNK end-labeled 30-nucleotide G-rich primer 
(50 pM) alone or with increasing Est1 levels (5, 10, 25, 50, 75, 100, and200 nM).  
Reactions were carried out at room temperature in TMG-30 buffer supplemented with 
BSA 200 g/mL, 200 mg/mL poly[d(I-C)]. The free probe is indicated with an arrow. 
 
 58
 
 
 
 
Figure 14. Est1 binds both single-stranded and hybrid/single-stranded DNA. (A.) 
The single-stranded DNA length required for Est1 (100 nM) binding was determined 
using primers (250 pM) with the indicated lengths. (B.) The ability of Est1 (100 nM) to 
bind to hybrid DNAs (250 pM) with single/double-stranded sections was determined 
using substrates with varying 3’-overhang lengths, as specified. The DNA electromobility 
shift assays contained the indicated Est1 protein amounts in TMG-30 buffer 
supplemented with BSA 200 g/mL, 200 mg/mL poly[d(I-C)], and end-radiolabeled 
oligonucleotide. The single-stranded primers were based on GTGGGTGTGTGTGTG 
(15mer) with additions to the 5’ end accounting for the longer sequences—GG (17mer), 
TGTGTGG (22mer), GTGTGTGTGG (25mer), TGGTGTGTGTGG (27mer) or 
GGGTGGTGTGTGTGG (30mer). To create the hybrid single-/double-stranded 
substrates shorter complimentary oligonucleotides were annealed to the 5  end of the G-
rich 30mer. The generated 3 -overhangs varied in length from 3 bases 
(ACCCACACACACCCACACACACCACC), 7 bases 
(ACACACACCCACACACACCACCC), 15 bases (CCACACACACCACCC), or 22 
bases (CACCACCC). 
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Figure 15. Est1 nucleic acid binding is mutually exclusive. An RNA/DNA competition 
assay was used to determine if the Est1 DNA and RNA binding activities are exclusive. 
Est1 (100 nM) was incubated with radiolabeled 30-base single-stranded DNA primer 
(250 pM) alone or with increasing amounts of unlabeled TLC1 RNA(0.25, 0.5, 1.0, 2.0, 
4.0, or 8.0 nM), as marked.  After a 20 minute incubation at 25 °C, the samples were 
resolved on a 6% native polyacrylamide gel in 1 XGTG buffer (90 mM Tris, 29 mM 
taurine, and 0.7 mM EDTA), the polyacrylamide gel was dried and the products were 
visualized with a PhosphoImager. 
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Figure 16.  Est1 up-regulates the telomerase DNA extension activity independent of 
DNA interactions.  (A.) The capacity of Est1 (50 nM) to stimulate telomerase-mediated 
DNA extension using substrates with various 3’-overhang lengths was determined.  To 
demonstrate that the DNA extension products were telomerase-dependent the telomerase 
extracts were tested using a DNA substrate with a C-rich 3’-overhang.  (B.) The Est1 
ability to affect free or DNA-bound telomerase was determined by altering the order of 
addition for Est1/BSA (50 nM), and the telomerase extract on a 7-base DNA substrate. 
The (A) indicates that Est1/BSA was added to reactions after telomerase had been pre-
incubated with the DNA. The (B) indicates that Est1/BSA was pre-incubated with the 
DNA before the addition of telomerase to the reaction. The positions of the loading 
control primer and the various +1 DNA extension products are marked. 
 
 
Est1:
 Overhang:  7 CAC 7 GTG 12 GTG 18 GTG 24 GTG Est1
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Figure 17.  Defects in nucleic acid binding and telomerase stimulation are non-
correlative for Est1 derivatives.  The Est1 point mutants Est1-38, Est1-41, Est1-42, 
Est1-49, Est1-50 and Est1-60 were purified to near homogeneity and characterized.  (A.) 
The RNA binding activity of each derivative (100 nM) was determined by EMSA using a 
radiolabeled TLC1 RNA (250 pM). (B.) The DNA binding activity of each derivative 
(100 nM) was determined by EMSA using a radiolabeled single stranded G-rich 30 base 
oligonucleotide (250 pM).  (C.) The ability of the various Est1 proteins (50 nM) to 
enhance telomerase DNA extension activity was examined.  The positions of +1 and the 
loading control primer are specified.  (D.) The capacity of Est1 to interact with Est2 
independent of TLC1 RNA was examined in vitro.  Est1 (500 ng) was added to either 
IgG sepharose alone or IgG sepharose preincubated with either ProA-Est2 + Tlc1 or 
ProA-Est2.  Est1 loading (20% input) control data is shown.  (E.) The abilities of wild-
type Est1, Est1-60 and Est1-41 to interact with Est2 in the absence or presence of TLC1 
RNA were determined using Est2 protein immobilized on IgG sepharose.  Representative 
data from 3 independent experiments is shown.  For the pull-down experiments the Est1 
proteins were visualized by western blot analysis using an antibody directed against the 
His6-tag.  Est2 loading control data is shown where the [
35
S]Met-labeled Est2 translation 
products were resolved by SDS-PAGE and visualized using a PhosphoImager.   
 
 
 62
CHAPTER 4
*
 
DISCUSSION 
 
 The telomere protein system has a variety of activities, including protecting, 
extending and replicating the terminal DNA in order to maintain the chromosomal ends 
(Figure 1). Although telomeres from all eukaryotes perform similar functions, detailed 
studies in budding yeast make it a particularly useful model system. During each cell 
cycle the telomere protein composition transitions from one complex to the next 
depending upon phase and marked need. For example, at telomeres with relatively short 
telomeric DNA tracts, the organization will fluctuate from an M-phase capping complex 
(minimally Cdc13–Stn1–Ten1) to a G1 capping structure that includes YKu70–YKu80-
stabilized telomerase (core subunits) to the DNA replication machinery in S-phase to a 
DNA resectioning assemblage (involving the MRX complex and the ExoI and SaeI 
nucleases) that degrades a segment of the C strand in late S phase to a DNA-extending 
structure (telomerase–Est3–Est1–Cdc13) for the G-rich 3’-overhang strand to a DNA 
polymerase a complex (Pol1, Pol12 and primase) that fills in the complementary C-strand 
during S/G2 and then returns to the capping structure found in M phase (Figure 1). In 
addition to this route, the telomere structure can remain capped throughout the cell cycle. 
The decision to follow an extendable or unextendable path is determined, in part, through 
a counting mechanism involving the number of double-stranded telomeric DNA motifs 
(i.e. length of terminal DNA), the Rap1–Rif1–Rif2 protein complex, and the telomere-
                                                
*
 Figures in this chapter were modified from DeZwaan DC and Freeman BC. (2010) 
HSP90 manages the ends. Trends Biochem. Sci., 35: 384-91. 
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associated kinases Tel1 and Mec1 (Shore and Bianchi, 2009). Intriguingly, Hsp82 
interacts with at least one operational component required for each of these telomere 
events (highlighted in red in Figure 1). But what functional role does Hsp82 have with 
these various factors? The telomere system is confronted with difficulties that might be 
alleviated with the assistance of a molecular chaperone. Specifically, telomeres face 
significant protein motility challenges; there is a need to transition between multiple 
structures and so individual telomere assemblies require mobility to function efficiently 
(e.g. telomere lengthening requires telomerase repositioning) and the system must avoid 
potential competitive DNA-binding events that would otherwise sterically interfere with 
function (e.g. Cdc13, Est1 (ever shorter telomeres), MRX, Stn1– Ten1 and telomerase are 
all single-stranded, G-rich DNAbinding proteins) (Gilson and Geli, 2007; Shore and 
Bianchi, 2009). Although there are a number of possible explanations to account for the 
various challenges, I favor a model in which the telomere environment is maintained in a 
dynamic state by the HSP90 machinery. If telomeres were governed by dynamic 
remodeling, then the individual components would exchange rapidly, fostering efficient 
transitions between complexes and avoiding competitive binding events through transient 
DNA interactions.  
 Cdc13 plays a central role in yeast telomere biology, as it is required to nucleate 
both capping and extending complexes to the DNA ends (Pennock et al., 2001). Genetic 
studies demonstrate that Cdc13 protects chromosomal termini along with Stn1– Ten1 and 
is required to extend the telomeric DNA in conjunction with the telomerase holoenzyme 
(Gilson and Geli, 2007; Shore and Bianchi, 2009). To determine whether Hsp82 
influences Cdc13-mediated events, I helped to establish an in vitro system in which 
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Cdc13 alone could stimulate telomerase DNA extension activity, but an unextendable 
telomeric DNA structure formed in the co-presence of Stn1–Ten1 (DeZwaan et al., 
2009). Significantly, addition of Hsp82 dissociated the Cdc13–Stn1–Ten1–DNA complex 
but did not impede the ability of Cdc13 to stimulate telomerase. Hence, Hsp82 permitted 
a transition between the capping and extending assemblies without interfering with the 
positive telomerase regulatory events provided by Cdc13. Whether this disassembly 
activity explains why HSP82 is a high-copy suppressor of the cdc13-1 and stn1-157 
mutations remains unknown. However, the ability of Hsp82 to promote DNA 
dissociation (i.e. Cdc13) and association (i.e. telomerase) of different telomere proteins 
might account for the extensive interaction network between Hsp82 and telomere 
proteins, as it would create a self-organizing telomere environment. 
 To illustrate, I expand upon the conceivable events that occur in late S phase 
when telomeres are directed to either extendable or unextendable states  (Shore and 
Bianchi, 2009). Initial expectations posited that all telomeric DNA would be lengthened 
during the duplication of each chromosome (Shampay and Blackburn, 1988; Blackburn et 
al., 1989). However, direct testing showed that individual telomere size is not increased 
in every cell cycle (Teixeira et al.,  2004). Furthermore, the extended telomeres displayed 
a sizeable variability in the amount of DNA added, as the interquartile range in extension 
length was 14–80 nucleotides. To account for the distribution in extension lengths, 
telomeres must be governed by a system that reacts continuously to regulatory signals 
and can control telomerase action before and after each added telomeric DNA repeat. To 
be able to respond to the incoming signals, I suspect that the HSP90 chaperone system 
maintains the telomere environment in a dynamic state (Figure 18). In this model, Hsp82 
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promotes the continual dissociation of the unextendable complex (Cdc13–Stn1–Ten1), 
which will reform unless the requisite components and signals for constructing the 
extendable structure are present. For example, assembly of the telomerase holoenzyme is 
restricted to S-phase because the essential Est1 subunit is expressed only at this point of 
the cell cycle (Osterhage et al., 2006). In addition, the actions of certain kinases (e.g. 
cyclin-dependent kinase 1 (Cdk1) and Tel1) appear to guide telomeres towards the 
requisite state by minimally modifying Cdc13. Cdk1-mediated phosphorylation likely 
disfavors Cdc13 interactions with Stn1 and fosters association with Est1 (Li et al., 2009). 
In addition, the Tel1 kinase is required for telomere DNA maintenance, and its potential 
phosphorylation targets include Cdc13 and the MRX complex subunit Xrs2 (Nakada et 
al., 2003; Tseng et al., 2007). However, the precise mechanistic contributions of Tel1 
signaling are incompletely understood. 
 After nucleation of the modified telomerase holoenzyme at a telomere, Hsp82 and 
its co-chaperone Sba1 are likely to promote a cyclical telomerase action, as Hsp82 
supports DNA binding by telomerase and Sba1 dissociates telomerase DNA complexes 
(Toogun et al., 2007; Toogun et al., 2008). How Hsp82 promotes binding while Sba1 
facilitates release is not clear, though it might occur through a chaperone-mediated 
opening and closing of the DNA-binding cleft. Nevertheless, rapid cycling of telomerase 
on and off the telomeric DNA would be beneficial for effective extension of the 
chromosomal termini. Following sufficient telomeric DNA lengthening, Sba1-mediated 
dissociation of the telomerase complex and action by unidentified phosphatases (which 
would reverse the influence of the Cdk1 and Tel1 kinases), are likely to promote the 
reformation of the Cdc13–Stn1–Ten1 unextendable structure. Hence, by maintaining the 
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telomere components in a dynamic state, the Hsp82 chaperone machine would permit the 
system to transition efficiently between different operative states, which are guided by 
post-translational modifications and the presence of the required subunits; the chaperone-
mediated interchange would also foster effective action for complexes that require 
movement (e.g. telomerase-mediated DNA extension). 
 In order to understand how complexes transition effectively, it is also necessary to 
grasp the functional role(s) of the individual components that come together to form these 
multi-subunit structures.  In the case of the telomerase extending complex an essential 
component, Est1, remained uncharactierized for years due to an inability to purify the 
protein.  The lack of functional Est1 information made understanding the mechanism and 
potential role(s) of the extending complex complicated.  However, I was able to 
successfully and reproducibly purify Est1 and through my extensive biochemical 
characterization of Est1 in conjunction with previous EST protein data, the field is 
beginning to shed light on a model of EST protein function in telomerase extension. 
Based on the available data, I favor a model in which yKu70/80 initiates telomerase 
telomere association then, depending upon the available components, the enzyme will 
assimilate into an “EST” holoenzyme structure (Figure 19).  The relative stability of the 
assembling complex will vary according to which components are present.  For example, 
Est1 expression is restricted to S-phase and Est3 is reliant upon Est1 to associate with 
telomerase (Osterhage et al., 2006).  Therefore, nucleation of the telomerase EST 
holoenzyme is only possible during this stage of the cell cycle, which likely limits the 
timing of telomeric DNA extension to S-phase (Marcand et al., 2000).  
 I suspect that the EST proteins cooperatively associate to both control telomerase 
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activity and to stabilize the telomere-bound structure.  Such reliance would explain the 
co-dependence for telomere interactions by the EST proteins (Taggart and Zakian, 2003; 
Fisher et al., 2004; Chan et al., 2008).  Hence, a disruption in any one of the holoenzyme 
subunits would result in declined telomere occupancy for all the components.  
Conversely, localization of any single subunit to a telomere should nucleate the entire 
holoenzyme.  For instance, tethering either Est1, Est3 or Cdc13 near a DNA end, either at 
a natural telomere or a HO-induced double-strand break, is sufficient to nucleate an 
active telomerase complex (Evans and Lundblad, 1999; Hughes et al., 2000; Bianchi et 
al., 2004).  In addition to the EST connections, genetic interactions between yKu70/80 
and Est1 or Est2 have been reported (Evans and Lundblad, 2002; Stellwagen et al., 
2003).  Unfortunately, the only assay (ChIP) capable of detecting in vivo protein DNA 
interactions cannot differentiate between recruitment and stability effects, as it relies on a 
chemical crosslinker to capture the bound complexes.  Thus, it is difficult to distinguish 
whether a factor delivers or steadies protein DNA assemblies in vivo.  
 Compelling points to consider yKu70/80 as the primary telomerase recruitment 
factor are the relative magnitude of yKu70/80’s effect on Est2 telomere occupancy and 
the sufficiency of yKu70/80 to engage telomerase at a telomere in G1 (Fisher et al., 2004; 
Chan et al., 2008).  If, however, yKu70/80 normally initiates loading of telomerase, then 
why isn’t there a more significant telomere DNA maintenance phenotype (length is stably 
reduced ~2-fold) in yku70D yeast (Porter et al.,1996)?  Perhaps the shared ability to bind 
telomeric DNA by yKu70/80, Est1, Cdc13 and telomerase circumvents a reliance on any 
single factor to engage telomerase at a telomere.  Given the catastrophic physiological 
outcome of even a single critically shorten telomere (i.e., replicative senescence) it would 
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seem prudent that compensatory mechanisms exist to overcome deficiencies (Hemann et 
al., 2001).  Since individual telomeres do not need to be lengthened in each cell cycle 
(Teixeira et al., 2004), a less efficient telomere recruitment route (i.e., Est1-mediated) 
might suffice in the absence of the primary pathway (e.g., yku70D yeast).  If Est1 isn’t 
the main telomerase recruitment factor then why is Est1 so critical for telomerase DNA 
maintenance? 
 Biochemical work has provided insights into the direct regulatory contributions 
that Est1 makes to telomerase.  Purified Est1 binds selectively to both telomeric DNA 
and the Tlc1 RNA bulged-stem loop (Vitra-Pearlman et al., 1996; DeZwaan and 
Freeman, 2009). the in vitro RNA binding specificity agrees with in vivo work 
(Livengood et al., 2002; Seto et al., 2002).  However, my work found that neither nucleic 
acid interaction appears to be required to control the enzymatic activity of telomerase 
(DeZwaan and Freeman, 2009).  Rather, Est1 associates directly with the Est2 reverse 
transcriptase to stimulate enzymatic activity.  Comparably, human Est1A can directly 
bind to the human telomerase protein subunit in the absence of the RNA template (Redon 
et al., 2007).  Hence, the main influence of Est1 on telomerase in vitro is to stimulate its 
DNA extension activity by directly contacting the reverse transcriptase protein. 
 In addition to Est1, Cdc13 has been shown to stimulate the DNA extension 
function of telomerase in vitro. (DeZwaan et al., 2009). While both Est1 and Cdc13 have 
innate abilities to modulate telomerase activity, at concentrations that likely reflect 
physiological levels neither protein displayed a significant effect (DeZwaan and 
Freeman, 2009).  Notably, it was shown that Est1 and Cdc13 could jointly up-regulate 
telomerase activity at lower protein amounts and the cooperative Est1 Cdc13 effect was 
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dependent upon the 252/444 salt-bridge.  Of note, the Est1-60 protein did not efficiently 
activate telomerase even at high concentrations (DeZwaan and Freeman, 2009).  In 
conjunction with the available ChIP data, the telomere DNA maintenance phenotypes of 
the est1-60 and cdc13-2 yeast likely result from a defect in telomerase up-regulation 
rather than impaired telomere recruitment (Evans and Lundblad, 1999; Pennock et al., 
2001; Taggart et al., 2002; Chan et al., 2008; DeZwaan and Freeman, 2009).  
 I suspect that the interaction between Est1 and Cdc13 also stabilizes an EST-
holoenzyme to the telomeres, which would account for the observed minor decline in 
telomerase telomere occupancy in the cdc13-2 yeast (Chan et al., 2008).  Though a lesser 
Est1 Cdc13 role in telomerase recruitment cannot be disregarded.  However, since a more 
significant decrease in telomerase telomere occupancy can be observed without inducing 
an EST phenotype (i.e., yku70D yeast), I believe that the Est1 Cdc13 interaction 
primarily impacts regulation of telomerase DNA extension activity.  
 In conclusion, telomere protein biology serves as an excellent molecular paradigm 
to understand how the efficiency of a single system can impact homeostasis, as telomere 
dysfunction can lead to either cellular senescence or uncontrolled growth (i.e., cancer).  
Given the number of employed proteins with common binding specificities (Figure 1), a 
decline in telomere efficiency is highly plausible due to complex misassembly or 
impaired structure disassembly.  The fundamental properties of molecular chaperones 
(abundant proteins with promiscuous but weak binding activities) would help proteins in 
the telomere system like Cdc13, Stn1, Ten1 or Est1 (low abundance, most likely having 
stronger binding activities) avoid these challenges by cultivating a self-organizing 
environment.  In essence, the ability of the HSP90 chaperone network to foster telomere 
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protein dynamics parallels the more established molecular chaperone roles in protein 
folding in which a chaperone does not dictate the final folded structure (path direction) 
but rather helps the nascent chain (system) avoid off-pathway energy barriers that 
commonly occur in protein folding (multi-step) energy landscapes.   
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Figure 18. HSP90 maintains the telomere environment in a dynamic state that 
permits rapid and efficient reactions to incoming signals and components.  In late S 
phase, telomeres are guided to either a telomerase extendable state or maintained in a 
protective unextendable form depending upon the length of the adjacent telomeric DNA 
(Shore and Bianchi, 2009).  In order to transition to a required structure during the 
narrow time frame afforded in late S phase, telomere structures are likely continuously 
disassembled and reassembled into various complexes depending upon the available 
components (e.g., Stn1–Ten1 vs. telomerase–Est1–Est3) and local signals (e.g., Cdk1 and 
Tel1 kinases).  In yeast, Hsp82 fosters both dissociation (protection components) and 
association (extension subunits) of telomere structures.  In conjunction with the Sba1 co-
chaperone that destabilizes the extension complex, telomeres are able to efficiently 
transition between the different functional states in order to properly maintain the 
chromosomal termini.  
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Figure 19. Est1 stimulation of telomerase enzymatic activity is critical for proper 
telomere DNA lengthening. Before telomere-association the telomerase holoenzyme 
assembles through an interaction between Est1 and the bulge-stem loop region of the 
TLC1 RNA.  The Ku70/80 protein complex recruits telomerase to the telomere through 
the association with a different segment of the TLC1 RNA. At the telomere, Est1 
interacts with Cdc13 via their salt-bridge and this association helps to stabilize the 
enzyme so it can fully assemble. Once assembled, Est1 and Cdc13 synergistically 
stimulate telomerase to extend the DNA.  
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CHAPTER 5 
MATERIALS AND METHODS 
 
 Telomeres are specialized nucleoprotein complexes found at the ends of eukaryotic 
chromosomes that serve at least two functions: (1) DNA end protection and (2) linear 
DNA length maintenance (McClintock, 1941; Watson, 1972).  The majority of 
Eukaryotes use an enzyme known as telomerase to sustain the telomeric end (Gilson and 
Geli, 2007).  The core of telomerase is composed of a reverse transcriptase (Est2 in yeast) 
and an RNA template (Tlc1 in yeast) (Singer and Gottschling, 1994; Lingner et al., 
1997).  The telomerase holoenzyme consists of two additional co-factors (Est1 and Est3 
in yeast), however, their telomere maintenance function(s) in association with telomerase 
are not well understood.  The G-rich single-stranded DNA of the telomere is also 
recognized and bound by a multitude of other proteins to form a variety of telomere-
protein assemblies including chromosome extending, capping and replicating complexes 
(Smogorzewska and de Lange, 2004; Gilson and Geli, 2007).  Significantly, the Hsp90 
machinery has been shown to affect multiple telomere components, however, its potential 
roles with these complexes have remained unclear (Holt et al., 1999).  The focus of this 
chapter will be to describe several methodologies designed to help understand the roles of 
various proteins involved in telomere maintenance. The specific goals of these assays 
were to characterize the telomerase co-factor Est1 as a means of understand its function 
with telomerase and also to explore the role(s) the Hsp90 molecular chaperone is 
performing with different telomere-proteins assemblies, including the capping complex 
and the telomerase holoenzyme. 
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Materials and Reagents 
For the assays: 
[1] Isopropyl -D-thiogalactopyranoside (IPTG) (Sigma). 
[2] DEAE fast flow sepharose (Pharmacia-LKB) 
[3] ResourceQ resin (Pharmacia-LKB) 
[4] MonoQ resin (Pharmacia-LKB) 
[5] Superdex-200 size exclusion column (Pharmacia-LKB) 
[6] Monoclonal Anti-HA-Agarose (Sigma) 
[7] IgG Sepharose 6 Fast Flow (GE) 
[8] Streptavidin Magnesphere Paramagnetic Particles (Promega) 
[9] [-32P]GTP (MP Biomedical) 
[10] [-32P]ATP (MP Biomedical) 
[11] [-32P] UTP (MP Biomedical) 
[12] [35
S
] Methionine (MP Biomedical) 
[13] Chicken egg white lysozyme (USB) 
[14] Micro-concentrator (Amico) 
[15] Raffinose/Galactose (Difco) 
[16] 10xAmino Acid drop-out mixture (Sigma) 
[17] -Factor 
[18] Amino acids (His, Ura, Trp, Leu, Lys, Arg, Gln)  
[19] dNTPs (Amersham Biosciences) 
[20] ATP 
[21] Creatine Phosphate/Creatine Kinase (Sigma) 
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[22] NaF, -Glycerophosphate, Na3VO4 (Phosphotase Inhibitors) 
[23] Talon Metal Affinity Resin (Clontech) 
[24] Yeastar Yeast Genomic DNA isolation kit (Zymo Research) 
[25] T’n’T Quick Coupled System (Promega) 
[26] Ampicillin, Kanamycin, Streptomycin  (USB) 
[27] RNasin RNase Inhibitor (Promega ) 
[28] Polydeoxy(Inodsinate-Cytidylate) (dIdC) 
[29] T7 Maxishortscript In Vitro Transcription Kit (Ambion) 
[30] RNeasy Mini kit (Qiagen) 
[31] Speed vacuum 
[32] Hybridization oven (Bellco) 
[33] Crosslinking machine (Spectro-Linker) 
[34] -Aminoadipate 
 
Specific equipment needed: 
[1] Fast performance liquid chromatography (FPLC) system (Pharmacia-LKB) 
[2] Phosphoimager (Molecular Dynamics) 
[3] Precision water baths of which the temperature can be regulated ± 0.1°C 
[4] DNA Sequencing gel rig (Owl Separation Systems) 
[5] Heated sand blocks 
[6] Electromobility shift assay gel running apparatus 
[7] 18 °C and 30 °C shaker for batch cell growth 
[8] Replica Plating apparatus 
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1. Expression of Est1 in bacteria cells: 
[1] Recombinant expression of wild type Est1 was best accomplished using the pET28-
Est1 construct. 
[2] For recombinant expression of Est1 we used Rosetta Escherichia coli cells (Novagen) 
transformed with the pET28-Est1 construct. 
NOTE [1]: The Novagen Rosetta cells are designed to enhance the expression of 
eukaryotic proteins that contain codons rarely used in E. coli. These strains supply tRNAs 
for AGG, AGA, AUA, CUA, CCC, GGA codons. 
[3] Luria-Bertani (LB) Media: dissolve 37.5 g LB media in dH2O (total volume 1.5 L) 
then autoclave. 
[4] Inoculate the transformant into a 500 mL LB flask (500 μL 35 mg/mL Kanamycin 
(Kan)) and allow to shake between 16-20 hours at 30 °C. (Overnight culture) 
[5] Seed eight 1.5 L LB (plus Kan) flasks with the overnight culture to an optical 
density595 (O.D.) of 0.1. 
[6] Let the 1.5 L cultures shake at 18 °C until the O.D. reaches 0.3. 
[7] Induce the cultures with 50 mM IPTG. 
[8] Allow the cultures to shake at 18 °C for an additional 45 minutes. 
[9] Clarify the cells (5,000 RPM, 7 minutes, 4 °C), keeping the remaining cultures on ice 
as it waits to be clarified. 
[10] Resuspend the bacterial pellet on ice in 10-15 mL of 1x Talon Binding Buffer (4 °C) 
with 1x Protease inhibitor cocktail (PI = Protease Inhibitor cocktail made of Aprotinin, 
Leupeptin and Pepstatin) and PMSF (both at 1 mM). 
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[11] Transfer the resuspension to a 50 mL conical on ice, and add 0.5 μg/mL chicken egg 
white lysozyme to the cells and nutate for 5 minutes at 4 °C. 
[12] Snap freeze the cells in a mixture of dry ice and methanol. 
[13] Perform a series of “freeze/thaws” in which the pellet is initially snap frozen (Step 
12) for ~10 minutes until completely solid, then the pellet is thawed at 37 °C until the 
pellet is just liquefied (~10 minutes). This cycle is repeated until there has been a total of 
four “freezes” and three “thaws”, ending on a freeze before storage at -80 °C. 
[14] 1x Talon Binding Buffer (50 mM KPO4 pH 7.0, 300 mM NaCl, 10% Glycerol). 
Store at 4 °C. 
 
2. Expression of Cdc13 in bacteria cells: 
[1] Recombinant expression of wild type Cdc13 was best accomplished using the pET28-
Cdc13 construct. 
[2] For recombinant expression of Cdc13 we used streptomycin-dependent SmP 
Escherichia coli cells transformed with the pET28-Cdc13 construct (Siller et al., 2010). 
NOTE [2]: The SmP cells were used since they slow the translational rate of proteins, 
allowing for more time for nascent proteins to fold properly.  
[3] Luria-Bertani (LB) Media: dissolve 37.5 g LB media in dH2O (total volume 1.5 L) 
then autoclave. 
[4] Inoculate the transformant into a 500 mL LB flask (500 μL 35 mg/mL Kan; 500 μL 
200 mg/mL Streptomycin) and allow to shake between 16-20 hours at 30 °C. (Overnight 
culture) 
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[5] Seed eight 1.5 L LB (plus Kan, no Streptomycin needed at this point) flasks with the 
overnight culture to an O.D.595 of 0.1. 
[6] Let the 1.5 L cultures shake at 18 °C until the O.D. reaches 0.3. 
[7] Induce the cultures with 100 mM IPTG. 
[8] Allow the cultures to shake at 18 °C for an additional 4 hours. 
[9] Clarify the cells (5,000 RPM, 7 minutes, 4 °C) 
[10] Resuspend the bacterial pellet on ice in 10-15 mL of 1x Talon Binding Buffer (4 °C) 
with 1x PI and PMSF. 
NOTE [3]: 1% NP-40 can be added to the 1x Talon Binding Buffer. 
[11] Transfer the resuspension to a 50 mL conical on ice, and add  0.5 μg/mL chicken 
egg white lysozyme to the cells and nutate for 5 minutes at 4 °C. 
[12] Snap freeze the cells in a mixture of dry ice and methanol. 
[13] Perform a series of “freeze/thaws” in which the pellet is initially snap frozen (Step 
12) for ~10 minutes until completely solid, then the pellet is thawed at 37 °C until the 
pellet is just liquefied (~10 minutes). This cycle is repeated until there has been a total of 
four “freezes” and three “thaws”, ending on a freeze before storage at -80 °C. 
[14] 1x Talon Binding Buffer (50 mM KPO4 pH 7.0, 300 mM NaCl, 10% Glycerol).  
Store at 4 °C.  
 
3. Expression of Stn1 or Ten1 in bacteria cells: 
[1] Recombinant expression of wild type Stn1 or Ten1 was best accomplished using the 
pET-DUET-Stn1 or pET-DUET-Ten1 construct. 
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[2] For recombinant expression of Stn1/Ten1 we used Rosetta Escherichia coli cells 
(Novagen) transformed with the pET-DUET-Stn1 or the pET-DUET-Ten1 construct. 
[3] Luria-Bertani (LB) Media: dissolve 37.5 g LB media in dH2O (total volume 1.5 L) 
then autoclave. 
[4] Inoculate the transformant into a 500 mL LB flask (500 μL 100 mg/mL Ampicilin 
(Amp)) and allow to shake between 16-20 hours at 30 °C. (Overnight culture) 
[5] Seed eight 1.5 L LB (plus Amp) flasks with the overnight culture to an optical 
density595 (O.D.) of 0.1. 
[6] Let the 1.5 L cultures of Stn1 shake at 30 °C until the O.D. reaches 1.0 (can also be 
done at 18°C) and let the 1.5 L cultures of Ten1 shake at 18°C until the O.D. reached 1.0. 
[7] Induce the cultures with 50 mM IPTG. 
[8] Allow the Stn1 cultures to shake at 30°C for 60 minutes (if at 18 °C, for an additional 
3hours). Allow the Ten1 cultures to shake at 18°C for 4 hours. 
[9] Clarify the cells (5,000 RPM, 7 minutes, 4 °C). 
[10] Resuspend the bacterial pellet on ice in 10-15 mL of 1x Talon Binding Buffer (4 °C) 
with 1x Protease inhibitor cocktail (PI = Protease Inhibitor cocktail made of Aprotinin, 
Leupeptin and Pepstatin) and PMSF (both at 1 mM). Ten1 should be brought up in 1x 
Talon Binding Buffer + 1% NP-40. 
[11] Transfer the resuspension to a 50 mL conical on ice, and add 0.5 μg/mL chicken egg 
white lysozyme to the cells and nutate for 5 minutes at 4 °C. 
[12] Snap freeze the cells in a mixture of dry ice and methanol. 
[13] Perform a series of “freeze/thaws” in which the pellet is initially snap frozen (Step 
12) for ~10 minutes until completely solid, then the pellet is thawed at 37 °C until the 
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pellet is just liquefied (~10 minutes). This cycle is repeated until there has been a total of 
four “freezes” and three “thaws”, ending on a freeze before storage at -80 °C. 
[14] 1x Talon Binding Buffer (50 mM KPO4 pH 7.0, 300 mM NaCl, 10% Glycerol). 
Store at 4 °C. 
 
4. Yeast (Saccharomyces cerevisiae) Growth: 
[1] Plate the Saccharomyces cerevisiae yeast on Yeast Extract, Peptone, Dextrose (YPD) 
plates and incubate for 1-2 days at 30 °C. 
[2] YPD Media: dissolve 50 g YPD media in dH2O (total volume 1 L) then autoclave. 
[3] Inoculate a 500 mL YPD overnight culture and shake between 18-36 hours at 30 °C. 
[4] Seed twelve 1 L YPD flasks with the overnight culture to an O.D.595 of 0.25. 
[5] Allow the cultures to shake at 30 °C until the O.D.595 reaches 1.0 
[6] Clarify the cells (3,000 RPM, 7 minutes, 4 °C) 
NOTE [4]: Resuspension Buffer is dependent on the type of yeast grown. 
[7] For yeast used to make telomerase extracts: Resuspend the cell pellet on ice in 25 mL 
of Lysis Buffer (4 °C). 
[8] For HA-epitope tagged yeast: Resuspend the cell pellet on ice in 15 mL of Tel1 
Buffer (4 °C). 
[9] For Tap-epitope tagged yeast: Resuspend the cell pellet on ice in 15 mL YEB Buffer 
(4 °C).  
[10] Clarify the cells (2,500 RPM, 5 minutes, 4 °C) 
[11] Snap freeze the cells in a mixture of dry ice and methanol and store at -80 °C. 
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[12] Lysis Buffer: 20 mM Tris pH 8.0, 1.1 mM MgCl2, 0.1 mM EDTA, 500 mM NaoAc 
pH 5.0, 10% glycerol, 0.1% Triton x-100 and 0.2% NP-40. Store at 4 °C. 
[13] Tel1 Buffer: 10 mM Tris pH 7.5, 100 mM KCl, 0.1 mM EDTA, 0.2% Tween-20, 1 
mM DTT, 1x Phosphotase Inhibitors, 1 mM PMSF. Store at 4 °C. 
[14] YEB Buffer: 245 mM KCl, 1 mM EDTA, 1 mM EGTA, 100 mM HEPES pH 6.9 
and 2.5 mM DTT. Store at 4 °C. 
NOTE [5]: Add the EGTA and DTT to the YEB Buffer immediately before usage. 
 
5. Est2 In Vitro Transcription and Translation: 
[1] Use the Quick Coupled Transcription and Translation (T’n’T) reaction kit from 
Promega. 
[2] Thaw the T’n’T on ice. 
[3] In a 1.5 mL snap cap tube on ice, add 40 μL of T’n’T Quick Master Mix. 
[4] To this add 2 μL [35S] Methionine, 1 μg T7-ProA-Est2, 1 μL T7 T’n’T PCR 
Enhancer and 3 μL dH20 (Friedman and Cech 1999). 
NOTE [6]: The T7 T’n’T PCR Enhancer must be added, otherwise the reaction does not 
work. 1 μg of the Tlc1 Mini-T plasmid can be added to incorporate Tlc1 into Est2 
(Zappulla et al., 2005). 
[5] Incubate the reaction for 90 minutes at 30 °C. 
[6] Place on ice or freeze at -20°C until usage. 
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6. Est1 Purification: 
[1] 1x Talon Binding Buffer (50 mM KPO4 pH 7.0, 300 mM NaCl, 10% Glycerol) 
[2] Talon Metal Affinity Resin (Clontech) 
[3] Imidazole 
[4] 20 mL Poly-prep chromatography column (Biorad) 
[5] FPLC 
[6] MonoQ resin 
[7] TenG Buffer (20 mM Tris pH 6.9, 0.1mM EDTA, 10% Glycerol) 
[8] TenG1 Buffer (20 mM Tris pH 6.9, 0.1mM EDTA, 10% Glycerol, 1 M NaCl) 
[9] TMG-30 pH 7.0 Buffer (20 mM Tris pH 8.0, 1.1 mM MgCl2, 0.1 mM EDTA, 10% 
Glycerol, 0.1% Triton x-100, 30 mM NaoAc pH 7.0) 
[10] Micro-concentrator (Amico) 
 
7. Cdc13 Purification: 
[1] 1x Talon Binding Buffer (50 mM KPO4 pH 7.0, 300 mM NaCl, 10% Glycerol) 
[2] Talon Metal Affinity Resin (Clontech) 
[3] Imidazole 
[4] FPLC 
[5] MonoQ resin 
[6] Superdex Size Exclusion Column 
[7] TenG Buffer (20 mM Tris pH 6.9, 0.1mM EDTA, 10% Glycerol) 
[8] TenG1 Buffer (20 mM Tris pH 6.9, 0.1mM EDTA, 10% Glycerol, 1 M NaCl) 
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[9] TMG-30 pH 7.0 Buffer (20 mM Tris pH 8.0, 1.1 mM MgCl2, 0.1 mM EDTA, 10% 
Glycerol, 0.1% Triton x-100, 30 mM NaoAc pH 7.0) 
[10] Micro-concentrator (Amico) 
 
8. Ten1 Purification: 
[1] 1x Talon Binding Buffer + 1% NP-40 (50 mM KPO4 pH 7.0, 300 mM NaCl, 10% 
Glycerol, 1% NP-40) 
[2] Talon Metal Affinity Resin (Clontech) 
[3] Imidazole 
[4] FPLC 
[5] MonoQ resin 
[6] Superdex Size Exclusion Column 
[7] TenG Buffer + 1% NP-40 (20 mM Tris pH 6.9, 0.1mM EDTA, 10% Glycerol, 1% 
NP-40). 
 [9] TMG-30 pH 7.0 Buffer (20 mM Tris pH 8.0, 1.1 mM MgCl2, 0.1 mM EDTA, 10% 
Glycerol, 0.1% Triton x-100, 30 mM NaoAc pH 7.0) 
[10] Micro-concentrator (Amico) 
 
9. Stn1 Purification: 
[1] Inclusion Body Wash Buffer (100 mM Tris pH 7.5, 100 mM NaCl) 
[2] 8 M Urea 
[3] Talon Metal Affinity Resin (Clontech) 
[4] Denaturing Buffer (50 mM Tris pH 8.0, 100 mM NaCl, 10 mM DTE, 8 M Urea) 
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[5] Refolding Buffer (100 mM Tris pH 7.5, 300 mM NaCl, 50 mM Arginine, 50 mM 
Glutamine) 
[6] 20 mL Poly-prep chromatography column (Biorad) 
[7] Imidazole 
[8] Elution Buffer (40 mM NaP pH 7.8, 300 mM NaCl, 500 mM Imidazole, 10 mM DTE, 
10 mM DTT, 1% NP-40) 
 
10. Telomerase Extract Preparation: 
[1] Lysis Buffer (20 mM Tris pH 8.0, 1.1 mM MgCl2, 0.1 mM EDTA, 10% Glycerol, 
0.1% Triton x-100,  0.2% NP-40, 500 mM NaoAc pH 5.0) Add RNasin RNA inhibitors 
immediately before usage. 
[2] Coffee grinder 
[3] TMG-500 pH 5.0 (20 mM Tris pH 8.0, 1.1 mM MgCl2, 0.1 mM EDTA, 10% 
Glycerol, 0.1% Triton x-100, 500 mM NaoAc pH 5.0) 
[4] TMG-1000 pH 5.0 (20 mM Tris pH 8.0, 1.1 mM MgCl2, 0.1 mM EDTA, 10% 
Glycerol, 0.1% Triton x-100, 1 M NaoAc pH 5.0) 
[5] FPLC 
[6] DEAE Resin 
[7] MonoQ resin 
[8] 1 mL and 3 mL syringe 
[9] TMG-30 pH 7.0 Buffer (20 mM Tris pH 8.0, 1.1 mM MgCl2, 0.1 mM EDTA, 10% 
Glycerol, 0.1% Triton x-100, 30 mM NaoAc pH 7.0) 
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[10] 80% Glycerol 
[11] Micro-concentrator (Amico) 
 
11. DNA-Binding EMSA: 
[1] 20x GTG Buffer ( 1.78 M Tris, 0.57 M Taurine, 10 mM EDTA) 
NOTE [7]: 20x GTG (Glycerol Tolerant Gel) is used to prevent gel distortions associated 
with samples that contain glycerol. Taurine does not react with glycerol while sodium 
borate does and will cause distortion. 
[2] EMSA electrophoresis apparatus 
[3] [-32P] ATP (MP Biomedical) 
[4] dIdC (Amersham Biosciences) 
[5] TMG-30 pH 7.0 Buffer (20 mM Tris pH 8.0, 1.1 mM MgCl2, 0.1 mM EDTA, 10% 
Glycerol, 0.1% Triton x-100, 30 mM NaoAc pH 7.0) 
[6] Native Loading Dye 
 
12. RNA-Binding EMSA: 
[1] 20x GTG Buffer ( 1.78 M Tris, 0.57 M Taurine, 10 mM EDTA) 
[2] EMSA electrophoresis apparatus 
[3] RNA-Binding Buffer (10 mM HEPES pH 7.8, 75 mM KCl, 2.5 mM MgCl2, 0.1 mM 
EDTA, 3% Ficoll) 1 mM DTT, Heparin (1mg/mL) and RNasin RNase inhibitor are 
added immediately before usage (Vitra-Pearlman et al., 1996). 
[4] T7 Maxishortscript In Vitro Transcription kit (Ambion) 
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[5] RNeasy Mini kit (Qiagen) 
[6] Native Loading Dye 
 
13. Telomerase Extension Assay: 
[1] 10 x Telomerase Buffer (500 mM Tris pH 8.0, 10 mM MgCl2, 10 mM Spermidine, 10 
mM DTT, 500 μM dTTP) 
[2] Streptavidin Magnesphere Paramagnetic Particles (Promega) 
[3] [-32P]GTP (MP Biomedical) 
[4] EcoRI Buffer (50 mM NaCl, 100 mM Tris pH 7.5, 10 mM MgCl2, 0.025% Triton x-
100) 
[5] Magnetic rack for 1.5 mL tubes 
[6] DNA sequencing electrophoresis apparatus (Owl) 
[7] Urea 
[8] Formamide Buffer + NaOH (80% Formamide, 10 mM EDTA, 1 mg/mL xylene 
cyanol, 1 mg/mL Bromophenol blue, 30mM NaOH)  
[9] Heated sand block (95 °C) 
[10] Speed Vacuum 
 
14. Co-Immunoprecipitation: 
[1] Quick Coupled T’n’T Master mix (Promega) 
[2] IgG Sepharose 6 Fast Flow 
[3] TMG Buffer (10 mM Tris pH 8.0, 1 mM MgCl2, 10% Glycerol) 
[4] Heated sand block 
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15. Telomere Southern: 
[1]Yeastar yeast genomic DNA isolation kit (Zymo Research) 
[2] Denaturing Buffer (87.6 g NaCl, 20 g NaOH up to 1 L dH20) 
[3] Neutralization Buffer (1.5 M NaCl, 1 M Tris pH 8.0) 
[4] 20x SSC (175.3 g NaCl, 88.2 g sodium citrate, pH to 7.0, adjust to 1 L with dH20) 
[5] Ekono Buffer (RPI) 
[6] Hybridization Oven 
[7] Crosslinker Machine (Spectro-Linker) 
[8] dNTPs 
[9] GTP 
[10] [-32P]GTP (MP Biomedical) 
[11] [-32P]ATP (MP Biomedical) 
[12] Nitrocellulose membrane (Amersham) 
[13] PCR Machine (Bio-Rad Thermocycler) 
 
16. Exo-T Nuclease Assay: 
[1] dIdC 
[2] Formamide Buffer + NaOH (80% Formamide, 10 mM EDTA, 1 mg/mL xylene 
cyanol, 1 mg/mL Bromophenol blue, 30mM NaOH) 
[3] [-32P]ATP (MP Biomedical) 
[4] DNA sequencing electrophoresis apparatus 
[5] Urea 
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17. Generating mutant Tlc1 yeast extracts: 
[1] 10 x Amino Acid drop out mix lacking Tryptophan 
[2] Yeast Nitrogen base without amino acids (Simple Media)  
[3] Dextrose 
[4] -Aminoadipate 
[5] Replica plating apparatus 
 
Methods 
1. Est1 Protein Purification: 
[1] Thaw the Est1 pellet at 37 °C (H20 bath) for ~ 10 minutes or until it is completely 
liquefied with no ice chunks, then immediately put it on ice and add 1x PI/PMSF. 
[2] Sonicate the sample on ice using a large tip at 50% duty on a 7 level output for 20 
seconds continuously. 
NOTE [8]: Repeat the pulse until the consistency is close to that of H20. The sample 
should be chilled between pulses so that it does not overheat. 
[3] Clarify the sample (17,000 RPM, 20 minutes, 4 °C) 
[4] While clarifying, pre-wash the Talon metal affinity resin by aliquoting  ~5mL Talon 
bead slurry into a 50 mL conical, clarify (2,500 RPM, 2 minutes, 4 °C), dump the 
supernatant (S/N). 
[5] Add 20 mL of 1 x Talon Binding Buffer (1xTBB) to resuspend the beads (Wash #1), 
clarify as before and dump S/N. Repeat this wash step one additional time and leave the 
beads on ice until the sample is ready to be added. 
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[6] Transfer the clarified Est1 S/N to the 50 mL conical that contains ~5 mL of pre-
washed Talon Affinity Beads, add 1x PI/PMSF. 
[7] Nutate the sample/beads for 1 hour at 4 °C.  Clarify the sample (2,500 RPM, 2 
minutes, 4 °C), dump S/N. 
[8] Resuspend the beads in 20 mL 1xTBB + PI/PMSF and re-clarify as above, repeat this 
wash step two additional times always making sure that PI/PMSF are added. 
[9] The sample/beads should now undergo a series of Imidazole washes via a gravity 
flow column (20 mL BIO-RAD Poly-Prep Chromatography Column) using increasing 
concentrations of Imidazole to wash away E. coli contaminating proteins: 
Wash A =  Add 10 mL of a 10 mM Imidazole/1xTBB (PI/PMSF) solution to the beads 
and then add the solution to a gravity flow column at 4 °C. Allow the entire 10 mL to 
flow through before adding the next wash, discard flow through. 
Wash B =  Add 10 mL of a 20 mM Imidazole/1xTBB (PI/PMSF) solution slowly along 
the side of the column wall to avoid disrupting the bead bed. Allow the solution to 
completely flow through, discard flow through. 
Wash C =  Add 10 mL of a 40 mM Imidazole/1xTBB (PI/PMSF) solution as before  
Elution =  Add 7.5 mL of 100 mM Imidazole/1xTBB (PI/PMSF) and collect the flow 
through in a new 50 mL conical. 
[10] Equilibrate the 7.5 mL elution with 22.5 mL of chilled TenG Buffer. 
[11] Load this 30 mL sample onto a 1 mL Resource Q ion-exchange column at a 1 
mL/min flow rate. 
[12] To remove additional E. coli contaminants, wash the column for ~5 minutes in 450 
mM TenG. 
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[13] Collect 1 mL fractions right when you set the gradient of 1000 mM TenG for 3 
minutes.  
[14] Concentrate (3,700 RPM, 4°C) the fractions in an Amico-microconcentrator (Add 
PI/PMSF prior to concentration) until the volume is ~100 μL. 
[15] Equilibrate with 2 mL of chilled TMG-30 pH 7.0 buffer (PI/PMSF) and re-
concentrate as above until the volume is 100 μL. 
[16] Transfer the solution to a 1.5 mL tube on ice. 
NOTE[9]: The protein must be used within 24 hours of purification, as it is extremely 
unstable. For the best result use Est1 immediately after purification.  
 
2. Cdc13 Protein Purification: 
[1] Thaw the Cdc13 pellet at 37 °C (H20 bath) for ~ 10 minutes or until it is completely 
liquefied with no ice chunks, then immediately put it on ice and add 1x PI/PMSF 
[2] Sonicate the sample on ice using a large tip at 50% duty on a 7 level output for 20 
seconds continuously. 
NOTE [10]: Repeat the pulse until the consistency is close to that of H20. The sample 
should be chilled between pulses so that it does not overheat. 
[3] Clarify the sample (17,000 RPM, 20 minutes, 4 °C) 
 [4] While clarifying, pre-wash the Talon metal affinity resin by aliquoting  ~5mL Talon 
bead slurry into a 50mL conical, clarify (2,500 RPM, 2 minutes, 4 °C), dump the 
supernatant. 
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[5] Add 20 mL of 1 x Talon Binding Buffer (1xTBB) to resuspend the beads (Wash #1), 
clarify as before and dump the supernatant. Repeat this wash step one additional time and 
leave the beads on ice until the sample is ready to be added. 
[6] Transfer the clarified Cdc13 supernatant to the 50 mL conical that contains ~5 mL of 
pre-washed Talon Affinity Beads, add 1x PI/PMSF. 
[7] Nutate the sample/beads for 35 minutes at 4 °C.  Clarify the sample (2,500 RPM, 2 
minutes, 4 °C), dump the supernatant. 
[8] Resuspend the beads in 20 mL 1xTBB + PI/PMSF and re-clarify as above, repeat this 
wash step two additional times always making sure that PI/PMSF are added 
[9] Wash in 1 M NaCl 1xTBB, nutating for 10 minutes at 4 °C. 
(1xTBB is already 300mM NaCl, so 7 mL 5M NaCl into 43 mL 1xTBB) 
[10] Elute with 10 mL  elution buffer (5 mL 1xTBB, 3 mL dH20, 1 mL 1 M Imidazole 
and 1 mL 80% Glyercol.  Add 5mL of this mixture initially to the beads and nutate at 4 
°C for 15 minutes, clarify (2,500 RPM, 2 minutes, 4 °C) and save the supernatant on ice. 
[11] Add the final 5 mL of the Imidazole mixture to the beads and nutate at 4°C for 10 
minutes, clarify as before and add this to the saved the supernatant. 
[12] Re-clarify (2,500 RPM, 2 minutes, 4 °C) the supernatant to remove any residual 
Talon resin. 
[13] Take the 10 mL elution and add 30 mL TenG Buffer to equilibrate the salt. 
[14] Load the 40 mL sample onto a ResourceQ column (2 mL/min) and allow the UV to 
baseline. 
[15] Wash with  TenG + 100 mM NaCl to remove additional E. coli contaminants and 
allow UV to baseline 
 92
[16] To elute the protein: 
Full length Cdc13 = 100-300 mM NaCl gradient for 6 minutes (flow rate: 2 mL/min, 
collect    0.75 mL fractions) 
DNA-Binding Domain of Cdc13 = 100-500 mM NaCl gradient for 6 minutes (flow rate: 
2 mL/min, collect 0.75 mL fractions). 
[17] Run out 10 μL of each fraction (5 μL 2xSB) on a 12% SDS-PAGE (240 V for 40 
minutes). Concentrate the relevant fractions to ~200 μL in an Amicon microconcentrator 
(3,700 RPM, 4 °C for as long as it takes) 
[18] Inject the sample into a Superdex sizing column equilibrated in TMG-30 pH 7.0 
(flow rate: 0.25 mL/min) collect 0.6 mL fractions 
[19] Run out 10 μL of each fraction (5 μL 2xSB) on a 12% SDS-PAGE (240 V for 40 
minutes). Concentrate the relevant fractions to ~100 μL in an Amicon microconcentrator 
(3,700 RPM, 4 °C for as long as it takes), and store the sample at -20 °C. 
 
3. Ten1 Purification: 
[1] Thaw the Ten1 pellet at 37 °C (H20 bath) for ~ 10 minutes or until it is completely 
liquefied with no ice chunks, then immediately put it on ice and add 1x PI/PMSF. 
[2] Sonicate the sample on ice using a large tip at 50% duty on a 7 level output for 20 
seconds continuously. 
[3] Clarify the sample (17,000 RPM, 20 minutes, 4 °C). 
[4] While clarifying, pre-wash the Talon metal affinity resin by aliquoting  ~5mL Talon 
bead slurry into a 50 mL conical, clarify (2,500 RPM, 2 minutes, 4 °C), dump the 
supernatant (S/N). 
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[5] Add 20 mL of 1 x Talon Binding Buffer (1xTBB) + 1% NP-40 to resuspend the beads 
(Wash #1), clarify as before and dump S/N. Repeat this wash step one additional time 
and leave the beads on ice until the sample is ready to be added. 
[6] Transfer the clarified Ten1 S/N to the 50 mL conical that contains ~5 mL of pre-
washed Talon Affinity Beads, add 1x PI/PMSF. 
[7] Nutate the sample/beads for 40 minutes at 4 °C.  Clarify the sample (2,500 RPM, 2 
minutes, 4 °C), dump S/N. 
[8] Resuspend the beads in 20 mL 1xTBB + 1% NP-40 + PI/PMSF and re-clarify as 
above, repeat this wash step four additional times always making sure that PI/PMSF are 
added. 
[9] Elute with 10 mL  elution buffer (5 mL 1xTBB + 1% NP-40, 2 mL dH20, 1 mL 1 M 
Imidazole and 1 mL 80% Glyercol.  Add 5 mL of this mixture initially to the beads and 
nutate at 4 °C for 15 minutes, clarify (2,500 RPM, 2 minutes, 4 °C) and save the 
supernatant on ice. 
[10] Add the final 5 mL of the Imidazole mixture to the beads and nutate at 4°C for 10 
minutes, clarify as before and add this to the saved the supernatant. 
[11] Re-clarify (2,500 RPM, 2 minutes, 4 °C) the supernatant to remove any residual 
Talon resin. 
[12] Take the 10 mL elution and add 30 mL TenG + 1% NP-40 Buffer to equilibrate the 
salt. 
[14] Load the 40 mL sample onto a ResourceQ column (2 mL/min) 
[15] Immediately start collecting the flow through as one large fraction. (Ten1 will flow 
through the MonoQ, while the other contaminates will stick to the resin) 
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[16] Concentrate the large fraction in an Amicon microconcentrator (3,700 RPM, 4 °C 
for as long as it takes) to a volume of ~1 mL. 
[17] Inject the sample into a Superdex sizing column equilibrated in TMG-30 pH 7.0 
(flow rate: 0.25 mL/min) collect 0.6 mL fractions. 
[18]  Run out 10 μL of each fraction (5 μL 2xSB) on a 12% SDS-PAGE (240 V for 40 
minutes). Concentrate the relevant fractions to ~100 μL in an Amicon microconcentrator 
(3,700 RPM, 4 °C for as long as it takes), and store the sample at -20 °C. 
 
4. Stn1 Purification: 
[1] Thaw the Stn1 pellet at 37 °C (H20 bath) for ~ 10 minutes or until it is completely 
liquefied with no ice chunks, then immediately put it on ice and add 1x PI/PMSF. 
[2] Sonicate the sample on ice using a large tip at 50% duty on a 7 level output for 20 
seconds continuously. 
[3] Clarify the sample (17,000 RPM, 20 minutes, 4 °C), discard the S/N and keep the 
pellet. (The pellet can be stored at -20°C at this stage for future usage). 
[4] Thaw the Stn1 pellet at 30 °C (H20 bath) for ~5 minutes and place immediately on 
ice, add 1xPI/PMSF. 
[5] Resuspend the pellet in 15 mL (~5 mL/ 1 g) chilled Inclusion Body Wash Buffer, 
transfer the resuspension to a 50 mL conical tube on ice. 
[6] Add an additional 15 mL of Inclusion Body Wash Buffer supplemented with 5% 
Triton x-100. Make sure that the pellet has been completely resuspended with no chunks. 
[7] Nutate the sample for 25 minutes at 4 °C. 
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[8] Clarify the sample (17,000 RPM, 20 minutes, 4 °C), discard the S/N and keep the 
pellet. Rinse the pellet with 10 mL Inclusion Body Wash Buffer. 
[9] Dissolve the pellet in 15 mL chilled 8 M Urea, vortexing vigorously until the pellet is 
completely dissolved (resuspended). 
[10] Clarify the sample (17,000 RPM, 20 minutes, 4 °C). 
[11] While clarifying, pre-wash the Talon metal affinity resin by aliquoting  ~1mL Talon 
bead slurry into a 1.5 mL tube, clarify (3,000 RPM, 1 minutes, 4 °C), dump the 
supernatant (S/N). 
[12] Add 1 mL of 8 M Urea to resuspend the beads (Wash #1), clarify as before and 
dump S/N. Repeat this wash step three additional time and leave the beads on ice until 
the sample is ready to be added. 
[13] Transfer the clarified Stn1 S/N to a 50 mL conical on ice. Add the ~1 mL of pre-
washed Talon Affinity Beads, add 1 mM DTE. 
[14] Nutate the sample/beads for 30 minutes at 4 °C.   
[15] Apply the mixture to a gravity flow column (20 mL BIO-RAD Poly-Prep 
Chromatography Column) at room temperature and allow the liquid to flow through 
completely. 
[16] Apply 5 column volumes (CV) of Denaturing Buffer to the beads and allow the 
liquid to completely flow through. 
[17] Apply 10 CV of Refolding Buffer to the column and allow the liquid to completely 
flow through, then cap the column and incubate on ice for 1 hour. 
[18] With the column still capped, apply 200 μL of Elution Buffer to the beads, mixing 
up and down and then transferring to a 1.5 mL tube. 
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[19] Nutate the beads in the Elution Buffer for 10 minutes at 4 °C. 
[20] Clarify the sample (3,000 RPM, 1 minute, 4 °C), transfer the S/N to a fresh 1.5 mL 
tube and re-clarify to remove any residual beads. Transfer the S/N to a fresh 1.5 mL tube 
on ice and Stn1 is ready for usage. 
 
5. Telomerase extract preparation: 
[1] Put the ~5 mL frozen yeast pellet on dry ice until you are ready to pulverize it. 
[2] Chill 20 mL of Lysis Buffer on ice and add 1 mM PMSF,  1 mM DTT, 1 mM PI and 
600 units of RNasin RNase inhibitor.  
[3] Pre-chill a coffee grinder to 4 °C, add a small piece of dry ice to the coffee grinder 
and pulverize the ice to pre-chill the inside of the grinder. 
[4] Add the frozen yeast pellet and an equal volume of dry ice to the coffee grinder and 
pulverize the sample until it is a consistent fine powder. 
[5] Add the powder slowly to the Lysis Buffer, and swirl to generate bubbling from the 
dry ice. 
NOTE[11]: There must be enough dry ice at this step, if the sample is “liquidy” once 
added to the Lysis Buffer due to lack of enough dry ice, the sample will not be good. 
[6] Cap the tube loosely to avoid an explosion due to the dry ice inside. Nutate the sample 
at 4 °C until the sample has become completely liquefied. 
[7] Clarify (17,000 RPM, 20 minutes, 4 °C), then pour the supernatant into a fresh 50 mL 
conical on ice that has a kimwipe placed over the opening.  This will remove any residual 
lipids and other unpelleted contaminants. 
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[8] Add the telomerase extract supernatant to DEAE fast flow sepharose (Flow rate 2 
mL/min). Allow the column to wash until the UV to baseline. 
[9] Elute the protein: 0-100% B gradient over 20 minutes (flow rate: 2 mL/min, collect 2 
mL fractions). 
NOTE[12]: This will give a single broad peak, and you only want to pool the first half of 
the peak stopping at the climax. The majority of the telomerase activity is in the first half 
of the peak. 
[10] Pool the relevant fractions and add chilled TMG-30 pH 7.0 Buffer to the sample in a 
ratio of 2:1 (e.g. 11 mL fractions to 22 mL TMG-30 pH 7.0 Buffer). 
[11] Apply the diluted sample to MonoQ resin (Flow rate: 1 mL/min). Set your timer to 
catch the sample when there is less than 0.5 mL left to be injected over the column so that 
you can catch the “salt bump”.  
NOTE[13]: As buffer begin to flow over the MonoQ resin, once the entire sample has 
been loaded onto the column, this creates a “salt bump” that dislodges the majority of the 
telomerase activity. 
[12] Immediately start collecting fractions (0.5 mL fractions) as the telomerase activity 
will come off quickly(usually fractions 2-6). 
[13] Concentrate the relevant fractions in an Amico-microconcentrator (3,700 RPM, 4 
°C) until the sample is ~100 μL. Dilute the sample with 2 mL TMG-30 pH 7.0 Buffer and 
re-concentrate to ~100 μL. 
[14] Add the sample to ~100 μL of pre-chilled 80% Glycerol, mix thoroughly, and store 
at -20 °C. 
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6. DNA-Binding Assay: 
[1] Cast a 6% Acrylamide gel using 20 x GTG as the buffer (usually takes 1 hour to set). 
Place the gel upright in an EMSA electrophoresis apparatus and add 1 L of 1xGTG 
Buffer. 
[2] To generate a hybrid telomere template: 
PNK-end label the longer of the two primers with [-32P]ATP. Clean the PNK-labeled 
sample by passing it through a mini-spin column (5,000 RPM, 5 minutes). Add equal  
amounts of the  [-32P]ATP –labeled primer to the shorter unlabeled primer in a 1.5 mL 
tube, mix (Total volume no more than 20 μL) , then boil in a 95 °C heated sand block for 
3 minutes. Take the entire sand block off of the heat and place it directly on the tabletop 
and allow the sand block (with the hybrid template inside) to cool to room temperature. 
Once at room temperature, pulse the sample (2,500 RPM) to remove the liquid that has 
condensed on the lid of the tube. The hybrid is ready to use, or can be stored at -20 °C. 
[3] Reactions are performed in 25 μL volumes. The protein of interest was added to 
TMG-30 pH 7.0 buffer along with 20 ng/μL dIdC, 0.2 μg/μL BSA and 250 pM DNA 
probe. 
[4] Incubate the reaction at room temperature for 20 minutes. 
[5] Add 1 μL of Native loading dye to each reaction and load onto the gel. Run the gel at 
150 V for 120 minutes. Dry and expose the gel. 
 
7. RNA-Binding Assay: 
[1] Cast a 6% Acrylamide gel using 20 x GTG as the buffer (usually takes 1 hour to set). 
Place the gel upright in an EMSA gel rig and add 1 L of 1xGTG Buffer. 
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[2] The RNA transcripts were synthesized using the T7 Maxishortscript in vitro 
transcription kit (Ambion) in the presence of [-32P] UTP and purified using RNeasy 
mini kit (Qiagen).  
[3] Transcripts were diluted to 32 nM, heat denatured (5 minutes at 95 °C) and snapped 
cooled before usage. 
[4] The 10 μL reactions including the protein of interest were performed in RNA-Binding 
Buffer incubated on ice for 20 minutes (Vitra-Pearlman et al., 1996). 
[5] Add 1 μL of Native loading dye to each reaction and load onto the gel. Run the gel at 
150 V for 120 minutes. Dry and expose the gel. 
 
8. Telomerase Extension Assay: 
NOTE[14]: Before performing an experiment you need to determine the amount of 
telomerase extract to use per reaction.  This can be done by making a dilution series of 1 
μL, 2 μL and 4 μL of a 1:100, 1:10 dilution and 1 μL, 2 μL and 4 μL straight. Perform 
these extensions on a 7-base overhang template and observe which dilution gives the 
preferred extension/intensity. 
[1] To make the biotinilyated overhang template (200 μL Final Volume): 
Mix 20 μL of 3’-Biotin modified telomerase oligonucleotide (100 μM), 20 μL of the 
specific overhang template oligonucleotide (100 μM), 10 μL 10x Annealing Buffer (100 
mM Tris pH 7.3, 500 mM NaCl) and 50 μL dH20. Boil for 3 minutes at 95 °C in a heated 
sand block. Then take the entire sand block off the heat and allow to cool to room 
temperature on the bench top. While cooling, pipette out 2 mL of Streptavidin 
Magnesphere Paramagnetic Particles (Promega) into a tube placed in a magnetic rack. 
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Pippette off the liquid and wash twice with 0.25 x SSC (1 mL per wash). Once the 
annealed overhang template has cooled to room temperature, add it to the paramagnetic 
particles, and allow to nutate at room temperature for at least 30 minutes. Then wash 
twice in TMG30 pH 7.0 Buffer (1 mL per wash) and bring to a final volume of 200 μL in 
TMG30 pH 7.0 Buffer and store at 4 °C. 
[2] Aliquot dilutions of your protein into labeled 1.5 mL tubes so that the final volume is 
5 μL (bring up to 5 μL in dH20 or TMG-30 ph 7.0 buffer). 
[3] Make a master mix sufficient for a 50 μL reaction volume per tube (5 μL 10x 
Telomerase Buffer, 1 μL [-32P] GTP, 1 μL overhang template, up to 50 μL dH20). 
Pipette the Master mix into the tubes containing the protein of interest.  
[4] Incubate at 30 °C for 30 minutes. Then place the tubes on a magnetic rack and allow 
the paramagnetic beads to collect against the side of the tube, pipetting off the 
supernatant into the radioactive trash. 
[5] Wash the paramagnetic beads twice (200 μL) with EcoRI Buffer and discard 
supernatant leaving only the beads. Add 50 μL of EcoRI Digestion mix to the beads ( 1 
μL EcoRI, 0.5 μL BSA (10 mg/mL) and 48.5 μL EcoRI Buffer per reaction). 
[6] Incubate at 37 °C for 1 hour, then place the tubes back on the magnetic rack and allow 
the beads to collect on the side of the tube. 
[7] Remove the 50 μL reaction liquid and transfer it to a fresh tube that contains a 
mixture of 5 μL 7.5 M NH4oAC and 4 μL Glycogen (10 mg/mL). Add 116 μL of 100% 
EtOH, mix by vortexing and place the tubes at -80 °C for 30 minutes or -20 °C overnight 
to precipitate the DNA. 
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[8] While the DNA is precipitating, cast a 12% Urea sequencing gel (19.2 g Urea, 4 mL 
5x TBE, 12 mL 40% Acrylamide up to 40 mL in dH20). Microwave mixture for exactly 8 
seconds and shake until all the urea has gone into solution. Add 200 μL 10% APS and 40 
μL TEMED, mix well and then use capillary action to cast the gel, tapping gently on the 
glass plates to avoid creating bubbles. Once solidified, set up the gel in the DNA 
sequencing electrophoresis apparatus and add 1x TBE as the running buffer. Start the gel 
pre-heating when you are ready to process your samples. 
[9] Take the samples from the -80 °C freezer and clarify (13,000 RPM, 20 minutes, 4 
°C). Pipette of the supernatant into the radioactive trash, then dry the samples in a speed 
vacuum for 10 minutes. 
[10] Add ~5-9 μL of Formamide + NaOH buffer, vortex for 5 minutes, then boil at 95 °C 
for 3 minutes in a heated sand block. Immediately place the samples on ice, then load the 
pre-heated gel. Once the samples have run the desired length, dry the gel and expose. 
 
9. Est1/Est2 Co-Immunoprecipitation: 
[1] Start by generating Est2-ProA (Friedman and Cech, 1999) using the T’n’T quick 
coupled Transcription & Translation Protocol (Promega) 
[2] Incubate at 30 °C for 90 minutes, then put on ice. 
[3] While performing T’n’T rxn, purify WT Est1 (Est1 Purification protocol) and 
determine its concentration. 
 [4] Pre-wash ~40 μL of IgG Sepharose 6 Fast Flow Bead slurry 2x with 1mL cold TMG 
Buffer (3,000 RPM, 30 seconds, 4 °C) 
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[5] Add 10 μL of Bead Slurry to the 50 μL T’n’T rxn, then nutate overnight at 4 °C in a 
1.5mL tube. 
[6] Clarify (3,000 RPM, 4 °C, 1 minute), pipette off the T’n’T liquid. 
[7] Immediately do 4x washes in 1 mL cold TMG Buffer, clarify as above 
(Beads should go from red to completely white in color). After the last wash, pipette off 
all the liquid, leaving only the beads. 
[8] Add Est1 (1-2 μg) to the beads and nutate for 10 minutes at 4 °C 
(as a control add an equivalent amount of Est1 to IgG Sepharose that underwent the same 
wash procedure but was not incubated with the Est2 T’n’T Rxn). Clarify as above, dump 
supernatant. 
[9] Wash beads 3x in 200 μL cold TMG Buffer, clarify as above. 
[10] After the final wash, pipette off all the liquid leaving only the beads, add 15 μL 
2xSB, boil for 3 minutes at 95 °C, then load onto a 12% SDS-PAGE gel (240 V for 40 
minutes). 
[11] Transfer to nitrocellulose via Western Blot 
(primary antibody = Anti-His    secondary antibody = Anti-mouse). 
 
10. Telomere Southern: 
[1] Yeast is grown at 30 °C (depending on the strain) to an O.D.595 ~ 1.0. Clarify the cells 
(3,000 RPM, 4 °C, 7 minutes), dump the supernatant and resuspend the pellet in 1 mL 
dH20. 
[2] Transfer the cells to a fresh 1.5 mL tube on ice and re-clarify (2,500 RPM, 2 minutes, 
4 °C), remove all the supernatant. 
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NOTE[15]: The pellet can be stored at -20 °C at this point until you are ready to use 
them. 
[3] Isolate the yeast genomic DNA using the Yeastar kit (Zymo Research). 
[4] Perform a 60 μL (final volume) XhoI restriction enzyme digest (enzyme depends on 
the assay) using 5-10 μg Yeast genomic DNA, 6 μL Buffer #2 (New England 
Biological), 0.6 μL BSA (10 mg/mL), 1 μL XhoI, up to 60 μL in dH20. Incubate at 37 °C 
overnight (or at least 6 hours if in a rush). 
[5] While the reaction is incubating, cast a 1% agarose gel by combining 500 mL 1x TAE 
with 5 g agarose, microwave 5 minutes, cool for 2 minutes and then pour into the gel cast 
at 4 °C (no EtBr is added at this point).  
[6] Make 3 L of 1x TAE (It takes 1.5 L to fill the gel running chamber). Save the last 1.5 
L of 1x TAE to replace the buffer later in the experiment. 
 [7] After the XhoI digest, add 1-5 μL of DNA loading dye directly to the sample and 
immediately load it onto the 1% agarose gel, flanking each side with a 1 Kb DNA ladder. 
[8] Run the gel until the dark blue dye front is ~ 1 inch from the bottom of the gel. 
NOTE[16]: If you are running the gel at 120 V, the buffer needs to be changed after 6 
hours. If the gels runs at 50 V, the buffer can be changed after 12 hours, at which point 
the voltage can be increased to 120 V to speed up the process. When changing the buffer, 
add 80 μL of EtBr to the fresh 1.5 L 1x TAE. 
[9] Image the gel to make sure the DNA has migrated to the point you desire. 
[10] Denature the DNA in 1 L of Denaturing Buffer, nutating for ~30 minutes or until the 
DNA disappears when re-imaging the gel. 
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NOTE[17]: The Denaturing Buffer can be reused up to 5x before a fresh solution should 
be made. 
[11] Neutralize the gel by nutating it in Neutralization Buffer for 30 minutes.  
[12] While the gel neutralizes, place a pre-cut nitrocellulose membrane (22.5 cm x 15 
cm) in a dish containing dH20 for 8 seconds, then transfer to a dish containing 20x SSC 
along with 3 pre-cut pieces of Whatman paper. 
[13] When the gel is neutralized, brake off the top (above the wells) and discard, flip the 
gel over and place it back-side-up on the transfer apparatus. Place the pre-soaked 
membrane on the gel (label a corner for orientation), removing any bubbles by rolling a 
test tube over the membrane. Place the 3 pre-soaked pieces of Whatman paper (one-by-
one) on top of the membrane, removing the bubbles as above. 
[14] Place two equal stacks of brown paper towels (~6 inches high) on top of the 
Whatman paper and place a small weight (300 g) on the top of the towels. 
[15] Allow the transfer to go overnight (or at least 6 hours). 
[16] While the samples are transferring make the probes:  
1. “Telo” Probe: 5 μL 10 μM “Telo” Probe stock, 5 μL PNK Buffer, 2.5 μL [-32P]ATP, 
36.5 μL dH20, 1 μL PNK enzyme. Incubate at 37 °C for 30 minutes, then clean the probe 
on a mini spin column (5,000 RPM, 5 minutes) and store at -20 °C or use immediately. 
2. “Cech Chromo IV” Probe (Control) (Friedman and Cech, 1999): 5 μL 10x Standard 
buffer, 5 μL W303g DNA template, 5 μL 10 μM “Chromo IV” probe primer, 10 μL 
dNTPs (dACT = 200 μM final), 1 μL cold dGTP (20 μM final), 5 μL [-32P]GTP, 18 μL 
dH20, 0,5 μL Taq Polymerase, setting up the components in order on ice. Pre-heat the top 
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of the PCR machine (hot top), perform 62 °C for 35 cycle program and store at -20 °C or 
use immediately. 
[17] After the transfer, take the membrane and soak it in 6x SSC for 15 seconds, then 
place the membrane on a paper towel to air dry for 2 hours at room temperature. 
[18] Crosslink the front and back of the membrane using the “optimal setting” on the 
Crosslinker machine (Spectro-Linker). 
[19] The membrane needs to be pre-hybridized in 25 mL of EKONO Buffer, rotating in a 
hybridization oven for 1 hour at 60 °C before the addition of the probes. 
NOTE[17]: Make sure to roll the membrane so that the front of the membrane is on the 
inside. 
[20] Add the two probes to 25 mL of fresh EKONO buffer, discard the used EKONO 
buffer before adding the new buffer to the membrane. Allow the membrane to rotate at 
least 6 hours (preferably overnight) at 60 °C. 
[21] Following hybridization the blot needs to be washed after dumping the EKONO 
buffer in the radioactive waste. Put the membrane in a Pyrex dish for the washes: 
1.) Wash #1 = 2xSSC + 0.5% SDS for 5 minutes, dump 
2.) Wash #2 = 2xSSC + 0.1% SDS for 15 minutes, dump 
3.) Wash #3 = 0.1xSSC + 0.1% SDS for 30 minutes, dump 
[22] Rinse the membrane quickly with 0.1xSSC, dump. Cover the membrane in cling 
wrap and expose. 
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11. Exo-T or Mung Bean Nuclease Assay: 
[1] PNK end-label a 15-base overhang template primer (Make the hybrid template as 
detailed in the “DNA-Binding Assay” protocol) 
[2] Pre-incubate the proteins of choice with the DNA template at room temperature for 5-
10 minutes. 
[3] Make a Master Mix (10 μL Final volume): 12.5nM hybrid template DNA (1μM 
stock), 20 ng/μL dIdC, 0.2 μg/μL BSA, 1μL Buffer #4 (New England Biological), 
1.25μL 80% Glycerol, up to 10 μL in dH20.  
[4] Add the protein(s) to the Master Mix and DNA (final volume 10μL), incubate at room 
temperature for 5 minutes. 
[5] Add 0.5 μL of ExoT or Mung Bean and incubate an additional 10 minutes at room 
temperature.  
[6] Add 10 μL Formamide NaOH buffer and boil for 3 minutes at 95 °C  (quenches 
reaction). 
[7] Put the samples on ice immediately, then load onto a pre-warmed 12% Urea gel 
(recipe for the urea gel is in “Telomerase extension assay” protocol). Dry the gel and 
expose. 
NOTE[18]: For an ExoT Time-Course: 
Test 1hr, 30min, 15min, 10min, 5min, 1min  and 0 minutes 
Set up 7 reactions, but only add ExoT to the 1hr reaction  
After 30 minutes add ExoT to the 30 minute reaction 
After 45 minutes add ExoT to the 15 minute reaction 
After 50 minutes add ExoT to the 10 minute reaction 
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After 55 minutes add ExoT to the 5 minute reaction 
After 59 minutes add ExoT to the 1 minute reaction 
After 1hr add ExoT to the 0 minute reaction 
Immediately add Formamide NaOH buffer to all the reactions, boil and load on Urea gel 
as above. 
 
12. Generating mutant Tlc1 yeast extracts: 
[1] Yeast (TCy43) expressing wild-type TLC1 from the pTLC1-LYS2-CEN plasmid 
were transformed with vectors for bulge-delete, stem-disrupt or stem-compensatory 
TLC1 RNAs. (pAS557 = Bulge Substitution, pAS558 = Bulge Deletion, pAS561 = Stem 
Compensatory, pAS562 = Stem Disruption) (Seto et al., 2002). 
[2] The transformants were plated on simple media plus dextrose plates lacking 
tryptophan (Trp) and lysine (Lys). 
NOTE[19]: Plating on this media maintains the wildtype plasmid, because the cells 
would die otherwise since they initially need the wildtype Tlc1 in order to grow.  
[3] The transformants will take ~2 days to grow at 30 °C (Catch the colonies as early as 
possible). 
[4] Replica plate onto -Aminoadipate plates to drop out the wildtype colonies that use 
the Lys2 or Lys5 pathway. Grow at 30 °C. 
NOTE[20]: Wildtype cells will always use the Lys2 or Lys5 enzyme pathways because 
they are more efficient, thus the cells will incorporate the -Aminoadipate into the 
Ly2/Ly5 pathway which is lethal. 
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[5] As a test, replica plate the -Aminoadipate plates onto Simple media and dextrose 
plates lacking 1.) Tryptophan 2.) Tryptophan and Lysine to observe if the cells lost the 
wildtype plasmid. Grow at 30 °C. The cells that grow on plates lacking only tryptophan 
have lost the wildtype plasmid.  
[6] Use the colonies on plates lacking Tryptophan to seed a 50 mL Simple media plus 
dextrose (SD) culture (Add in 5 mL 10x Amino Acid drop out mix lacking tryptophan). 
Shake the culture at 30 °C  until the O.D.595 is between 1.5-2.0 (exponential growth 
before stationary/lag phase). 
[7] Add the entire 50 mL culture to 1 L SD (100 mL Amino Acid drop out mix lacking 
Tryptophan).  
[8] Allow the culture to shake at 30 °C until the O.D.595 is between 1.5-2.0 (Save a 5-10 
mL aliquot at this stage to use in a Southern Blot). 
[9] Use this culture to seed eight 1 L SD (100 mL Amino Acid drop out mix lacking 
Tryptophan) flasks to an O.D.595 of 0.25.  
 [10] Allow the culture to shake at 30 °C until the O.D.595 is 1.0 (Save a 5-10 mL aliquot 
at this stage to use in a Southern Blot). 
[11] Clarify the cells (5,000 RPM, 7 minutes, 4 °C) and resuspend in 15 mL of chilled 
Lysis Buffer. Transfer to a fresh 50 mL conical, clarify (2,500 RPM, 5 minutes, 4 °C), 
dump the supernatant and snap freeze. 
[12] Use the yeast pellet to make a telomerase extract as described in the “Telomerase 
extract preparation” protocol. 
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[13] Take the saved samples and perform a southern blot (using the “Southern Blot” 
protocol with the “Telo” and “Cech Chromo IV” probes) to observe if the samples give 
the expected telomere shortening phenotype in vivo. 
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APPENDIX A
*
 
BIOCHEMICAL CHARACTERIZATION OF FULL LENGTH CDC13 
 
PURIFIED FROM SmP E. coli 
 
 Misfolding of eukaryotic proteins upon recombinant production in bacteria has 
placed great limitations on their biochemical and structural analyses and their therapeutic 
utilization (Baneyx et al., 2004; Pavlou et al., 2004).  In bacteria, folding of polypeptide 
nascent chains can be delayed relative to their synthesis (“posttranslational” folding), a 
process that may promote misfolding of certain recombinant proteins (Netzer and Hartl, 
1997; Agashe et al., 2004).  In contrast, the eukaryotic cytosol appears to be highly 
capable of efficiently folding protein domains as they emerge from the ribosome 
(“cotranslational” folding) (Netzer and Hartl, 1997; Agashe et al., 2004; Chang et al., 
2005).  Kingdom-specific molecular chaperones have been demonstrated to support each 
of these distinct folding regimes, including trigger factor (TF) in bacteria (Agashe et al., 
2004; Kaiser et al., 2006) and the ribosome-associated complex in fungi (Gautschi et al., 
2002).  In addition to their different chaperone complements, a major difference between 
bacteria and eukaryotes is their translation speed. In Escherichia coli, polypeptide 
elongation rates vary from 10 amino acids per second (aa/s) during slow growth to 20 
aa/s during fast growth (Pedersen, 1984; Liang et al., 2000).  In contrast, elongation rates 
in eukaryotes are thought to be fairly constant and considerably slower (3– 8 aa/s) 
                                                
*
 Data presented in this chapter were originally published in Siller E, DeZwaan DC, 
Anderson JF, Freeman BC and Barral JM. (2010) Slowing bacterial translation speed 
enhances eukaryotic protein folding efficiency. J. Mol. Biol., 396:1310-8.  I performed all 
of the presented experiments in this study. 
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(Matthews et al., 2000). Although ribosomal pausing at rare codons along mRNAs 
encoding particular proteins has been shown to affect their activities, (Kimchi-Sarfaty et 
al., 2007; Zhang et al., 2009) the effect of general variations in polypeptide synthesis 
rates on protein folding efficiency has remained largely unexplored. In this work, I aimed 
to study the impact of global changes in protein synthesis rates on de novo protein 
folding by utilizing streptomycin (Sm)-pseudodependent (SmP) ribosomes of E. coli, 
(Zengel et al., 1977) whose polypeptide elongation rates can be modulated by varying the 
concentration of Sm present in the growth medium.  
 SmP ribosomes contain mutations in protein S12 of their decoding center (see 
Materials and Methods) (Kurland et al., 1996).  In the absence of Sm, bacteria harboring 
these ribosomes display a “hyperaccurate” phenotype, with considerable reduction in 
translation rates (5 aa/s) and 20-fold increase in the accuracy of amino acid 
incorporation compared to wild type (Ruusala et al., 1984).  Addition of Sm relieves this 
phenotype in a concentration-dependent fashion, restoring translation speed to nearly 
wild-type levels, as reflected by restoration of growth rates (which correlate directly with 
protein synthesis speed) (Ruusala et al., 1984), albeit with a concomitant 7-fold increase 
in misincorporation rates compared to wild type (Ruusala et al., 1984).  Utilization of 
SmP ribosomes allowed us to focus on the effects of decreased polypeptide elongation 
rates on protein folding, since for every comparison between bacteria harboring 
slowribosomes (without Sm) and bacteria harboring fast ribosomes (with Sm), all other 
experimental parameters were identical and constant. 
 Previous data had established that firefly luciferase synthesized at slower speeds 
was more capable of acquiring its native state (Siller et al., 2010), I wished to determine 
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whether this effect was generally applicable to eukaryotic proteins prone to aggregation 
when synthesized in bacterial systems.  I investigated whether this approach could be 
successfully applied to large multidomain eukaryotic proteins previously shown to be 
inefficiently folded to their native state upon recombinant production in bacteria. I 
selected the telomere binding protein Cdc13 from S. cerevisiae (105 kDa), a protein 
essential for telomere maintenance that protects chromosome ends from damage and 
recruits the telomerase complex (Nugent et al., 1996; Pennock et al., 2001). Cdc13 
contains three distinct regions: an N-terminal telomerase recruitment domain, a central 
DNA binding domain, and a C-terminal capping region (Wang et al., 2000; Chandra et 
al., 2001).  The central DNA binding domain of Cdc13 has been expressed as a soluble 
and active species in E. coli, which has facilitated its biochemical and structural analyses 
(Mitton-Fry et al., 2004).  However, these analyses for the full length protein have been 
hindered by the inability of wild-type bacteria to yield native material. Similar to firefly 
luciferase and the GFP fusion proteins, it was observed that most of the full-length Cdc13 
protein was present in the soluble fraction when synthesized by SmP ribosomes under 
slow translation conditions (Siller et al., 2010). To assess whether the full length Cdc13 
produced in this manner was indeed native, I purified it (Figure 20) from the soluble 
fraction and compared its DNA binding activity to that of the central DNA binding 
domain (DBD) alone by electromobility shift assay (EMSA) (Toogun et al., 2007; Figure 
21). I found that the purified full length Cdc13 displayed DNA binding affinity and 
selectivity (i.e., 11-base length requirement) comparable to the well-characterized 
properties of the central DNA binding domain (Hughes et al., 2000). I then examined if 
Cdc13 produced in the SmP strain, maintained its ability to stimulate telomerase 
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extension activity.  Cdc13 and two Cdc13 point mutants (Cdc13-1 and Cdc13-2) were 
titrated into telomerase extension assays and found to stimulate extension to the same 
levels as previously observed and the mutants were able to stimulate comparable to full 
length Cdc13 (DeZwaan et al., 2009; Figure 22). 
 In this study, I investigated whether the fast polypeptide elongation rates of the 
bacterial ribosome could be responsible, at least partially, for the poor capacity of E. coli 
to fold proteins of eukaryotic origin, normally translated at the considerably slower speed 
of the eukaryotic ribosome. I found that, indeed, decreasing bacterial polypeptide 
elongation rates to rates similar to those of eukaryotes promotes the folding of Cdc13, 
which is prone to aggregate even when grown at low temperatures (18 °C).  I believe that 
these findings provide a general strategy for the production of recombinant proteins that 
does not rely on the individual manipulation of coding sequences or on the introduction 
of specific accessory factors. 
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Figure 20.  Purification of full-length and the DNA binding domain (DBD) of Cdc13 
from streptomycin (Sm)-pseudodependent (SmP) E. coli. Total lysates (T) were 
cleared by centrifugation and the supernatant fraction (S) was subjected to cobalt-affinity 
(C), MonoQ ion exchange (Q) and Superdex 200 size exclusion (E) resins. Aliquots of 
each chromatographic step and the final purified proteins (0.5 μg) were co-resolved by 
SDS-PAGE and the proteins were visualized by staining with Coomassie brilliant blue. 
Molecular weight markers (M), Cdc13 is ~103 KDa and the DBD is ~30 KDa.  
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Figure 21. Cdc13 purified from SmP E. coli cells binds single-stranded DNA.  
Electromobility shift assay was used to determine if the purified full-length Cdc13 (F; 
100 nM) or its DNA binding domain (D; 100 nM) could bind to single-stranded. The 
single-stranded DNA length required for binding was determined using telomeric 
oligonucleotides (50 pM) with the indicated lengths. Arrows mark the approximate 
position of the free probe. 
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Figure 22.  Cdc13 and its various mutants purified from SmP E. coli cells stimulate 
telomerase extension. The Cdc13 effect on telomerase-mediated DNA extension was 
tested using extracts prepared from YPH499 yeast with an immobilized 7-base 3’-
overhang DNA substrate. Telomerase DNA extension reactions were supplemented with 
BSA, Cdc13, Cdc13-1 or Cdc13-2 (0, 50, 100, 250, 500nM), as marked.  To serve as a 
loading control, an end-labeled 27-base primer was added prior to precipitation of the 
extension products. 
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APPENDIX B 
BIOCHEMICAL CHARACTERIZATION OF EST3 
 
 In Saccharomyces cerevisae, the telomerase holoenzyme is composed of three 
EST (Ever Shorter Telomere) proteins associated with an RNA template called TLC1 
(Singer and Gottschling, 1994; Lendvay et al., 1996; Lingner et al., 1997; Hughes et al., 
2000).  Est3 is one of the essential yeast telomerase co-factors required to promote 
telomere replication (Lendvay et al., 1996).  Previous work has demonstrated that Est3 is 
recruited to the telomerase complex via the cell cycle regulated Est1 telomerase co-
factor. Est3 is also dependent on the presence of Est2 for proper complex association 
(Hughes et al., 2000; Osterhage et al., 2006).  Once the telomerase complex has formed, 
however, the actual role Est3 plays in telomere regulation is not well understood.   
 To obtain a better appreciation for the function of Est3 with telomerase, I titrated 
purified Est3 into telomerase extension reactions that used a 7-base hybrid 3’-overhang 
template (Figure 23).  Est3 was able to stimulate telomerase extension activity, but 
required higher concentrations than were needed for Cdc13 (Figure 6) or Est1 (Figure 
10).  Since Est1 and Cdc13 have a positive combinatorial effect on telomerase extension 
activity, I wondered if the addition of the last EST protein (Est3) would further up-
regulate the extension activity observed. Various concentration combinations of the three 
EST proteins were incubated together, but no additional stimulation was observed (Figure 
24).  However, since Est3 can up-regulate telomerase on its own (Figure 23), various 
Est3 point mutants were employed to try to understand  its mechanism of action.  A triple 
(ETN) and double (DQ) point mutant that change the bases to alanine were used along 
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with the K71A mutant which has been shown to give shortened telomeres in vivo, while 
maintaining its ability to assemble with the telomerase complex (Jennell Talley 
communication).  The K71A and ETN mutants significantly decreased telomerase 
extension activation, while the DQ mutant up-regulated extension comparable to 
wildtype (Figure 25).  Perhaps the K71A mutation, which displays the greatest 
telomerase activation defect, disrupts the ability of Est3 to be recruited to telomerase 
through its interaction with Est1.  Additional characterization of all three Est3 mutants 
will need to be don before we can generate a more complete model to explain the 
regulatory role of Est3 with telomerase. 
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Figure 23.  Purified Est3 enhances telomerase DNA extension activity in vitro. The 
Est3 effect on telomerase-mediated DNA extension was tested using extracts prepared 
from YPH499 yeast with an immobilized 7-base 3’-overhang DNA substrate.  The DNA 
extension reactions were supplemented with BSA or Est3 (0.5, 1, 2.5, 5, 10 μM), as 
marked. An RNase control (R) was included to demonstrate that extension was 
telomerase dependent.  To serve as a loading control an end-labeled 27-base primer was 
added prior to precipitation of the extension products.  
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Figure 24. Est3 does not further enhance telomerase stimulation in the presence of 
Est1 and Cdc13.  The effects of the three EST proteins was tested using extracts 
prepared from YPH499 yeast with an immobilized 7-base 3’-overhang DNA substrate. 
The reactions were supplemented with 5nM Est1, Est3 and/or Cdc13, as marked. To 
serve as a loading control an end-labeled 27-base primer was added prior to precipitation 
of the extension products.  
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Figure 25. Est3 point mutants adversely affect telomerase extension activity. DNA 
extension reactions using an immobilized 7-base 3’-overhang DNA substrate were 
supplemented with either wildtype Est3 or the K71A, DQ or ETN Est3 point mutants 
(0.25, 0.5, 1, 2.5, 5μM), as marked. To serve as a loading control an end-labeled 27-base 
primer was added prior to precipitation of the extension products.  
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